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From the
President

Colleagues:
Now that summer is here, hopefully, we will
all have some time to enjoy the warm
weather and be able to get away from our
daily work routine for some relaxation.
As many of you know, the members of Allen
Neurosurgical Association (ANA) have
announced that after July 1, 1999, they will
no longer provide neurosurgical coverage of
the trauma service at Lehigh Valley Hospital
(LVH). This announcement appeared in the
Morning Call with an accompanying article
during the first week of June. The group
announced their intention to the LVH
administration in a letter dated March 8,
1999. Since that time, numerous
discussions have occurred between the
hospital administration, the Chairperson of
the Department of Surgery, the Chief of the
Trauma Service, and members of TROIKA
with representatives of ANA to address their
concerns related to trauma coverage.
Unfortunately, these discussions have not
met with success and it appears that the
remaining members of the group will
proceed with their intention to withdraw from
trauma coverage. We have been assured
that adequate coverage of neurosurgical
trauma has been secured and that the
trauma program will continue to function
without interruption as our hospital, its
medical staff, our patients and our
community have come to expect.
At the June General Medical Staff meeting,
there was a free ranging discussion of this
issue. This discussion, which was at times
contentious,_ provided an opportunity for the
medical staff members in attendance to

(Continued on Page 2)
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understand the issues involved and a chronological history of
the efforts to solve.this apparent impasse. Members ofthe
staff need to know that the Medical Staff Bylaws and the rules
and regulations of the Division of Neurosurgery require active
members of the staff to provide coverage for the Emergency
Room and the Trauma Program, unless excused by the
chairperson of the department in which the medical staff
member has his/her appointment. The implication of these
bylaws and rules and regulations is that if the members of ANA
do not provide coverage for the trauma program, the Medical
Executive Committee and the Board of Trustees of the hospital
will be forced to terminate the clinical privileges of the
members of ANA, thus, terminating their membership on the
LVH Medical Staff. This will truly be a "lose-lose" scenario for
both the institution and the members of ANA, who we have
valued as our professional colleagues for many years. This
will be a tragedy.
What lessons can we all learn from this unfortunate set of
circumstances, so that we can prevent the reoccurrence of a
similar episode in the future?
Since the beginning of my term as your President, I've been
trying to encourage a collaborative approach between the
Medical Staff and the hospital administration. Issues that
develop in the future need to be addressed by both sides
coming to the table to discuss them in an open and
collaborative way. The goal of any discussions should be to
find a mutually acceptable solution to controversies, which
hopefully, can satisfy the needs of both parties. We need to
begin to build relationships that are seen to be positive by their
commitment at the outset to solving problems in a mutually
satisfactory manner. Neither side should initiate discussions
with threats. Both sides need to understand the implications of
any controversy on the other. Sitting down with the "will" to
solve an issue, so that the result can be positive for both sides,
should be the goal. Our issues with the hospital administration
should not be approached as a labor negotiation to be solved
by threats of a "strike" or "taking our patients somewhere else."
The goals of the Medical Staff and the hospital should be to
build the best relationship, so that our patients and the
community can receive the highest quality medical care. We
need to remember that our primary responsibility as
physicians should be to our patients. Hopefully, if we keep
this in mind, we will be able to craft positive solutions to issues
that develop between this Medical Staff and our hospital
administration.
As physicians, many of us trained in the era when hospitals
were reimbursed by what they did for patients and the length of
time patients were admitted. The longer the patient stayed in
the hospital and the more we did, the better the hospital did
financially. I'm sure that many of you remember the culture,
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which developed during our medical school and residency
training, where we learned how to deal with "all" of the patier+'c:
problems and to order any test or procedure which might e\(
remotely be useful to the patient's care. We felt we were doing
a wonderful job for our patients by addressing all of their
problems, collecting "baseline" data for future records, and
doing tests and procedures for "academic interest." As they
say, "that was then and this is now.· Obviously, we all know
that reimbursement methods have changed. We now have
"prospective payment," "case based reimbursement,• DRG's,
managed care, capitation, PPO's, HMO's, PSO's, "risk
sharing,· etc. These changes in reimbursement have greatly
changed the way we practice. However, most of us still live in
the same culture in which we were trained. We haven't
learned how to practice in new and efficient ways, which will
allow us to continue to provide the highest quality patient care,
while still maintaining the financial solubility for our practices
and our hospital, which is necessary if we are to develop new
programs and techniques to care for our patients and our
community. We need to learn how to live in a "new culture"
different from the one in which we were trained - a culture
where we recognize that our nation's health care resources are
finite and limited. We need to learn to be the stewards of
these resources while still being the advocates for our
individual patients. Every day we need to think about ways in
which we can help to "take work out of the system." We need
to ask ourselves not "why didn't I order
.·but "why d~
order_." As I've asked you before, every time you order e:a
test or procedure, ask yourself "how is the result of this test or
procedure going to change the way I manage this patient?"
"Could the things I'm doing for my patient in the hospital today
be done in a more comfortable setting and at less expense in
some other setting?" Although there is still much "art" to the
practice of medicine, we should try, as much as possible, to
base our clinical decisions on evidence where it exists, and
not on anecdote and personal experience.
e;;Mail ,
,, .
..
·:1{5 ·aiVJays; I'd like to·encourag'ealhmembers Qf.th~; ·· ·
·Medic,aiStaff to read their~ailregulaiiy or;to designate · .·.
•a staffmemberJo be yourappointed ·~urtogate~ wlio ean ·
:read and piintout·your e-maiFmessages'foryou on :a daily ·
:basis: ·
··

Sit Answer and Touch!

Remember, when you are making hospital rounds, sit at your
patienfs bedside, ask for their questions, answer their
questions, and make physical contact with the patient.
(Continued on Page 3)
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Just last week, I had a conversation with a patient's daughter
who told me how very much it meant to her mother when the
doctor would come in her room and sit down at her bedside
and hold her mother's hand. This little gesture means a lot to
both the patient and their family.
Members of the Medical Staff will soon be receiving a
"Physician Satisfaction Survey." Even though it is long and
may be somewhat time intensive to complete, I encourage you
to complete and return this survey so that the hospital
administration can make the changes which will improve the
efficiency of our care, and help to improve physician
satisfaction with the hospital and its staff.
Also, some of you will be receiving a survey which has been
developed by Linda Lapos, chair of the Medical Records
Committee, to help us assess physician satisfaction with the
Lehigh Valley Hospital patient medical record. Your input into
this process will be greatly appreciated. Hopefully, based
upon the results of this survey, we will be able to make the
patient medical record more useful and easier for each of us to
use as we make our daily hospital rounds.

(

As many of you know, Dr. Joseph Gastinger is ill with ALS. He
is presently at home and requires a great deal of care from his
incredibly supportive wife and from others who have
volunteered their time to assist him. The Medical Staff has
established a fund to help Joe and his family meet the financial
burdens of his care. "The Joseph Gastinger Fund" will be
funded solely by contributions from members of the Medical
Staff and the hospital family who wish to help Joe and his
family during the period of his long illness. Individuals wishing
to make a contribution to the fund should make their check
payable to "The Joseph Gastinger Fund" and forward it to Beth
Martin, Medical Staff Services Office, Lehigh Valley Hospital,
Cedar Crest &1-78, P.O. Box 689, Allentown, PA 18105-1556.
Lastly, let's all work in a collaborative way for the betterment of
our patients. After all, are they not the primary reason that
leads us all to choose a career in medicine? Such an
approach will serve us best in the end.
Have a great month!

&aJl

David M. Caccese, MD
Medical Staff President
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Legislative Update
The Civil Justice Coalition, which includes the Pennsylvania
Medical Society, urges you to contact your Senator to
encourage their support for Senate Bill 5 introduced by
Senator Robert Thompson. The reform element in Senate Bill
~ ~at is o.f p~m~.ry interest to physicians is the repeal of
JOJntness 1n hab1hty. The principle of full comparative
responsibility in Senate Bill 5 protects physicians from being
seen as the "deep pocket• in liability cases who are held
responsible for someone else's error or mistake. There are
other reform provisions that require attorneys who file frivolous
suits be penalized and that juries be informed about additional
compensation a plaintiff may receive.
Obviously, this is a very important issue to physicians. Please
take a few minutes from your schedule to call or write your
Senator regarding Senate Bill 5. If you need the name,
addre~ or phone number of your Senator, please contact Mr.
Lou E1ster at the Lehigh County Medical Society at (61 O) 4372288 .or the Pennsylvania Medical Society, Government
Relations Department, at 1-800-228-7823, Ext. 1452.
There is also another initiative, on the national level, which
should interest physicians.
The American Association of Orthopaedic Surgeons has
created a 1-800 telephone number to allow individuals to
contact members of the U.S. House of Representatives to urge
them to co-sponsor H.R. 1304, the Quality Health Care
Coalition Act (also known as the Campbell Bill). The
legislation would allow physicians and other health care
professionals to enter into negotiations with health care plans
or other payers without violating antitrust laws. The telephone
number is 1-888-812-8824.

px~
Robert X. Murphy, Jr., MD
Legislative Chairman
Lehigh County Medical Society

/ . ' :. ·Gcisting~0Futid :e#ablished ·.·. · ·····
·=A ~fundw~·recentJ}' .e$taBlisn~d: to.·benefit . · ·

.~o~ep~''W~:~tinger, Mt> ;,and· hi~'family~ .· If

Y~LI w,ish t,()'tM.~e·a cor'ltr:(~uti~n~ pleCise'ft1~~ .
::yo~~ check·payoble. to~~Tfl~ J9~epb·,Gastinger

Fund"·,and send.Jt~to:Beth Martin~ Mtdicdlv$toff
,$ervlcesi ~ehigh}lalley . Hospitat;.'CedhrcCrest'& ·
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Gregory Brusko, DO, Named Vice
Chairperson of Surgery at MHC
At the June 1 Medical Executive Committee, Gregory Brusko,
DO, was appointed Vice Chairperson of the Department of
Surgery at Muhlenberg Hospital Center.
A member of the Medical Staff since August, 1995, Dr. Bruske
is a graduate of the Philadelphia College of Osteopathic
Medicine. He completed his internship at Allentown
Osteopathic Medical Center, followed by a four-year General
Surgery residency at Grandview Medical Center, Dayton, Ohio.
Dr. Bruske is certified by the American Osteopathic Board of
Surgery.
Dr. Brusko is a member of the practice of Toselli &Bruske
Surgical Associates, LTD, with offices in Bethlehem and
Allentown.
At th~~General Medicc1rstaff~rneeting 1 held on Mond~~-;:j
iune:14, the f()llowingitems were approved:

>
'>

The Medical Staff budget for fY 2006was.
approved as present~d: ·_
· .;
·DueS' assessments for FY-2000wert.approved·a5
foUows:
Dentists- all active will beasse5sed$25p;OO
Dentists - till associate will be asses'sed :$150.00
··All: Other Active staffwil_l be-assessed '$350:0Q. ·
All•dfher :Associate staff will be assessed

·:$'20o:oo ·.

->

_

.

. ...•

All members -of the M~dical :Staff who reachcthek :
6'5fh birthday on or before September· t·~999 will .
have their. dl.ies waived~< .
·
··
·
·111e designation of:Em~ri;tus was·elirni~atedfronr .
the· Medical Staff: Bylaws.. This~deslg~aticm.~i~ply_ ·-~
meansthatan in9ividuar'has reacf\~~"Ti1e:cag(or'65.'·
in their: particulciJ;; ~t~pcy~ Appi"p~imately.tw9
,years. ago this was made:an •optioi'\Jor ,individuals,' .
Since-this was an ag~,.relate~ ~e5igncifion rather . -·
'than_academichonor,it wasfeltthat·there·was,no,c:
loriger.a needf,or this/~refix to>staffcategocy.
I

Outpatient Cardiopulmonary Rehab
Department Opens at MHC
Muhlenberg Hospital Center is pleased to announce the
opening of the outpatient Cardiopulmonary Rehabilitation
Department. This new service is located on the first floor near
the visitors' lobby entrance and is easily accessible for
patients.
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The Cardiopulmonary Rehabilitation Department offers the
following programs and services:
(~
• Phase II Monitored Cardiac Rehabilitation
• Phase Ill Supervised Cardiac Rehabilitation
• Pulmonary Rehabilitation
• Vascular Rehabilitation
• Employee Wellness
• General Fitness
• Participant education and support
These programs are designed to enhance the recovery of
post-CABG, post-MI, and post-revascularization patients, as
well as improve functional capacity and symptom management
in patients battling chronic disease conditions such as COPD,
asthma, coronary artery disease, and peripheral vascular
disease.
Program participants work with a team of clinicians including
registered nurses, respiratory therapists, and exercise
physiologists to develop a lifelong habit of positive lifestyle
behaviors through specific, individualized treatment strategies.
Most of the programs require a physician order and preadmission requirements prior to program commencement.
Insurance coverage varies and is based on the policies of each
specific plan.
For patient referrals, more detailed program
(
information/requirements, facility tours, or to request
brochures, please call the Cardiopulmonary Rehabilitation
Department at (610) 861-2559. If you are interested in having
an informational presentation conducted for your office staff or
colleagues, please contact Terri Falcone, Program
Coordinator, at (610) 861-2559 or through e-mail.

Parking Changes/
Construction to Begin at
MHC
Approval was recently received to
begin Phase I construction of a new
two-story psychiatric facility and a central utility building
.
located on the campus of Muhlenberg Hospital Center. Due to
this construction, which is scheduled to begin in mid-July, a
series of parking changes will be necessary. When ground is
broken to begin construction, the Physical Therapy lot will
close. However, additional spaces will be constructed to
accommodate employee and physician parking.
Stay tuned for additional information as it becomes availablf(
If you have any questions regarding this issue, please contab.
Gerry Kresge, Director of Security, at (61 0) 402-8220.
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Implementation of IRS Fees
(

Rega~ing future new protocol submissions, the Lehigh Valley
Hosp1taUMuhlenberg Hospital Center Institutional Review
Board (IRB) will charge a $1,000 per protocol processing fee to
reimburse for overhead costs (protocol registration, file
maintenance, annual renewal, etc.). Any fees received beyond
overhead costs will be placed into a fund for resident research.
This policy becomes effective on July 1, 1999.

THIS POLICY APPLIES TO DEVICE· AND DRUG
COMPANY-SPONSORED PROTOCOLS ONLY. In-house,
student and other staff protocols are exempt.
Please include this fee in your budget as either an "indirect
hospital expense• or as a line item fee for IRB review,
especially if the sponsor already allows for this in their
paperwork.
THIS POLICY DOES NOT AFFECT PROTOCOLS IN
PROGRESS. If you have already finalized your budget, but
have not yet submitted the study for IRB review, these
protocols are exempt as well.

(

CLINICAL TRIALS PROTOCOLS will have a separate fee
schedule, which is yet to be determined.
Also, consent forms will NOT require a separate financial
disclosure/conflict of interest statement If you need a copy of
the IRS's current Consent Form Template, please contact
Bernadette Glenn, IRB Coordinator, at (610) 402-2529.

tamoxifen, the drug of choice. In the first Breast Cancer
Prevention Trial, in which the Morgan Cancer Center also
participated, tamoxifen showed a reduced chance of
developing breast cancer by about half.
"Studies of raloxifene suggest it has the potential to prevent
breast cancer,• said Elisabeth Ladd, director of Breast Health
Services. "The only way to prove that potential is to do a
clinical trial in which the risks and benefits of raloxifene are
directly compared with the risks and benefits of tamoxifen. •
Women who participate must be postmenopausal, at least age
35, and have had an increased risk of breast cancer
dete~in~ by their family history of breast cancer, personal
med1cal h1story, age at first menstrual period and age at first
live birth.
"Tell your family, your friends and your patients who might be
eligible about this study, • said Andrea Geshen, manager of the
Morgan Cancer Center's clinical services. "Because there is
no placebo, everybody who participates has the potential to
benefit."
On~e a wom~n chooses to participate, she will be randomly
ass1gned to either 20 mg tamoxifen or 60 mg raloxifene daily
~or fiv~ years and will have regular follow-up examinations,
mcludmg mammograms and gynecologic exams.

Up to 22,000 women nationwide are expected to be enrolled
in this double-blind, randomized clinical trial.

If you have any questions or concerns regarding this issue,
please contact Bernadette Glenn at (610) 402-2529 or Tom
Wasser, IRB Administrator, at (610) 402-2497.

T~moxifen has been used for almost 25 years to treat patients
with advanced breast cancer, and since 2985 as an adjuvant
or follow-up therapy after radiation and/or surgery for earlystage breast cancer. In October, the Food and Drug
Administration approved it for breast cancer prevention.

LVH Joins Second Major Breast Cancer
Prevention Trial

Women interested in participating can be seen at the
participating hospital closest to them. For more information
about the trial, call1-877-548-3805.

Lehigh Valley Hospital's John and Dorothy Morgan Cancer
Center is participating in one of the largest breast cancer
prevention studies ever, joining more than 400 other medical
centers in the United States, Canada and Puerto Rico.
The Morgan Cancer Center, which is also operating the Study
of Tamoxifen and Raloxifene (STAR) at Muhlenberg Hospital
Center, Gnaden Huetten Memorial Hospital, and Hazleton
General Hospital, is looking for women to join the study.

(

PageS

..

r-':/..

~: . .~.

' .· ·:.:

Peb~idernents ~: Due to a:.~he1119e:oir. the docu~entatiori
~ requirements. ~or .debridem~nts,:•sharp;Qeb~lderilent•
· can no longer~ be eoded t().· EJ<cisioncil :Deb'r,ideme~t·. · ·
~

'

Iri' order to code'Exdsiona! D~bria~ment; the word
'·eXcisional•
must.. be
documented
.
.,.
.. ·
··.
...
'

.STAR ~ill 7xamine ~hether the osteoporosis drug raloxifene
IS effective mpreventing breast cancer in women who are at
high risk for the disease and whether it offers benefits over

.

,,_..,

'

·;'·

Ifyo~'n(lve any questlo'ns;please·contact bill" ina Kutish ·· · .
',~VJ1;~?dir!1 Teafl) ~~er~at {6i9>;~0i;.2319, or Betty
,:Dieter~:MHCCO~JI'I9:Team.~der;, 1at~{610)86h8384. ·
I

'·

'

·.

.

' . ,.. ,. . .

,.,.,,,.·,

:·

o·.;

::·.:·:

,''·"··

.

Medical Staff Progress Notes

July, 1999 • Volume 11, Number 7

4A to Accept Higher Level Acuity
Patients
Beginning July 13, 1999, patient care unit 4A, located at Cedar
Crest & 1-78, will be able to handle higher level acuity patients.
Initially, the unit will accommodate up to four patients who may
require IV antiarrhythmic medications, nitroglycerine,
dopamine, or dobutamine. These patients are the type you
would admit to PCCU. In mid-August, 4A will be able to
handle eight higher level acuity patients. The need for a
further increase in number will be evaluated in September.
When this change occurs, PCCU will then keep up to four
patients on Med-Surg status. The goal of this plan i~ to
decrease patient transfers, increase patient satisfaction, and
increase the availability of low level monitored beds at Cedar
Crest & 1-78.
If you have any questions regarding this issue, please contact
Molly Sebastian, Director, ACUIPCCU, at (610) 402-8723, or
Bruce A. Feldman, DO, Medical Director, 4A, at (610) 4336442.
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value added activities. Strategies to be employed include
Work Sampling, Focus Groups, and Roadblock Assessme(
Phase I, which will be rolled out consecutively on two
·
Medical/Surgical units- 6B at Lehigh Valley Hospital, and 2S
at Muhlenberg Hospital Center (July and August, respectively)
- involves work sampling, a technique used to observe work
activities and estimate the proportion of time spent in a given
activity. This strategy provides an initial analysis of work
activities and clarifies what activities are being done by each
job function. Work Sampling will be followed up by Focus
Groups and Roadblock Assessments. Preliminary analyses
will begin in early August, and additional analyses and reports
should be completed for both sites by early October. All
together, these initial results will serve as a guide in identifying
work activities that require further "drill down" analyses, as well
as provide clarification for next steps.
For more information regarding this project, please contact
Yvonne Bryan, PhD, RN, Researcher, Patient Care Services,
at (610) 402-1704, or Deborah Halkins, Management
Engineer, at (610) 317-4842.

Helwig Diabetes Center of Excellence
Work Flow Analysis Initiative to be
Rolled Out in Patient Care Services
In mid July, Phase I of a Work Flow Analysis project,
sponsored by Care Management Council, will be rolled out in
Patient Care Services.
The purpose of this initiative is twofold:
1. To evaluate if systems are in place and operating at
optimum levels to assure service excellence and
innovation.
2. To determine whether the right people are in the right
place, doing the right work, and the right time, for
delivering quality, cost effective care.
The specific goals are:
1. To understand the efficiency and productivity of
designated processes, structures and job roles that impact
quality.
2. To understand the workload and determine the issues
which drive the work.
3. To understand the roadblocks that prevent quality service
by department or role.

The Helwig Diabetes Center of Excellence, a component o(
Circulatory Center, is a new initiative of Lehigh Valley Health
Network, which is being designed to meet the increasing
health care needs of individuals with diabetes in our hospital
and community. The goal of the center is to move from a
traditional episodic model of education to a multi-dimensional
comprehensive model, which will facilitate measurable
improvements in the health status of this population.
Currently, there are several diabetes services available,
however, many of these services function independently of one
another. The new initiative is designed to pull all of our
existing services together to facilitate collaboration and allow
patients to access care in an easier fashion. The Diabetes
Center of Excellence model will occur in a virtual sense,
however, without moving services. Existing services will be
augmented through the addition of new and innovative
programs that will include emphasis in the areas of prevention,
disease management, and research.

Ane$thesia PediatriC: Pre;.,edltati~no~ders •.·

;;For'rri #:Do 164: 1~ are nQW:~yililab'ft through. ·
)he Cof1Solidated ..Grap~i~·Pi~ ~:·F>:acforma~·a·.

:,.,Yrite~il'l em theform: :nji~~ are~50;form~·per ,·

~

Succinctly stated, this initiative is focused on understanding
"the work" of care delivery and the processes to deliver the
work, as well as identifying, quantifying, and eliminating non-

PQCk.
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Health Spectrum Pharmacy Services( Meeting the Needs of Your Patients
An Overview of Patient Care Services for the
Prescriber
Scope of Services
Health Spectrum Phannacy Services was founded in 1986 to
provide high quality, specialized phannaceutical care to the
region that it serves. In addition to traditional prescription
services, Health Spectrum is able to provide your patients with
a full line of ostomy care products as well as an extensive
assortment of orthotic appliances and supplies coordinated by
certified fitters. Through Health Spectrum Medical Products,
the needs of patients in skilled nursing facilities with
pharmacotherapy as well as medical equipment needs can
also be met.

(

Health Spectrum Infusion Services can provide you with the
option of specialized infusion therapies in the comfort of the
patient's residence -whether they live at home or in an
institutional setting. In the latter case, Health Spectrum
specialists will coordinate the care of the patient with the
housestaff. They work closely with a large number of
professional nursing agencies. The network of care which
results allows your patients to utilize parenteral or inhalation
therapies in an environment conducive to healing -the
patient's own environment.

Specialized Infusion Therapies
One of the hallmarks of the services provided by Health
Spectrum Phannacy is specialized infusion therapies.
Appropriately evaluated patients may be candidates for these
services in the comfort of their homes. These services include,
but are not limited to, the following:
Parenteral Nutrition
Hydration Therapy
Parenteral Pain Management
Anti-infective Therapy
Immune-enhancing Infusions, such as Intravenous
Immune Globulin
Antihemophilic Factor Infusions
Cancer Chemotherapy
Inotropic Drug Infusion
Terbutaline Infusion
Immunosuppressant Therapy
{

Health Spectrum's Nurse Specialists are certified in the
insertion of Peripherally-Inserted Central Catheters (PICC)
. lines. Insertion of this type of vascular access can greatly
enhance the quality of the parenteral therapy chosen by
decreasing the number of times the patient must be stuck to
infuse the required therapy. Also, PICC lines allow the
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administration of solutions with high osmolarity (Parenteral
Nutrition) or with high incidence of venous irritation and
phlebitis (Vancomycin, Nafcillin) by allowing central venous
administration of these therapies. PICC lines provide a
valuable option in the management of your patients.
Infusion Phannacists, as well as nursing personnel, are
available 24 hours a day, seven days a week, to address the
needs of your patients. Care is coordinated between Health
Spectrum and the various nursing agencies utilized to provide
the highest level of patient care. Health Spectrum Phannacy
Services is accredited by the Joint Commission for the
Accreditation of Healthcare Organizations (JCAHO).

Insurance and Payment Issues
Health Spectrum Phannacy Services will investigate all
aspects of reimbursement for the services that you order for
your patients. Whenever possible, the cost of therapy to the
patient will be spelled out prior to the initiation of services.
Health Spectrum Phannacy Services is a preferred provider for
many commercial insurance programs, and their
Reimbursement Specialists are available to answer any
questions that arise regarding the patient's responsibilities for
payment.
If you have a patient who requires specialized infusion services
or the need for a progressive phannacy practice, please
contact Howard C. Cook, Jr., RPh, Clinical Phannacist, Health
Spectrum Phannacy Services, at (61 0) 402-1968 or (800) 283-

7479.
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Lehigh Magnetic Imaging Center Update
New Open MRI Scanner

PageS

www.LehighMRI.com to learn more about special patient
services, the staff- including the interpretation specialties oj
LMIC's radiologists -the state-of-the-art MRI scanners, bill(
and insurance information, and much more.
·

Lehigh Magnetic Imaging Center (LMIC) is pleased to
announce the availability of its new open MRI system, the
Picker Proview. This new scanner represents the most
advanced, innovative technology available. The Proview
scanner produces the highest quality images at reduced
scanning times.

The web site also provides a detailed look at what patients can
expect during their MRI visit, from the time the appointment is
made through how their doctor will receive the results.
Knowing this information ahead of time can make a first-time
MRI appointment much more pleasant.

Key Advances

Collectibles Wanted for Walk-Through
History Display

MRI image quality is based upon key components including
gradient strength, post processing software, and specialized
imaging coils. The new open unit has the highest gradient
strength of any open MRI system. Strong gradients not only
improve image quality but also decrease scanning times. The
software will allow for faster computer reconstruction of MRI
images which further reduces scanning times. MRI imaging
requires the use of coils that send and receive signals that
produce the image. Advances in technology have produced
an array of new, innovative coils that LMIC has acquired as
part of the new scanner acquisition.

Most "Open" Scanner Available
The unique design of this open MRI unit provides the most
accessibility of all open MRI systems in the Lehigh Valley by
utilizing a c-arm design that is totally open on three sides of the
patient. The design of the scanner provides a comfortable
scanning environment for large and claustrophobic or anxious
patients. The patient enters the scanning area by a side entry'
approach, which alleviates the anxiety often associated with
head-first entry of claustrophobic patients into the scanning
area.

Specially Designed Suite
The design of the open MRI suite offers a spacious room, large
windows overlooking a landscaped view, and ceiling skylights
to allow natural light into the suite. Additional seating is
available for friends or family members who wish to
accompany the patient during the scan.
The new open MRI scanner at LMIC is now available for
patient appointments. To schedule an appointment for the
new open scanner or the high field scanner, please call Lehigh
Magnetic Imaging Center at (610) 740-9500. To arrange a
tour of the facility, please call Kathy Adams, Director of
Marketing, at (610) 740-9733.

Look LMIC Up on the Web
More information about the open Proview system, including
equipment photos and MRI images, can be found at LMIC's
newly-created web page. Type in the address -

Attention all physicians! The 1001h Anniversary Committee
would like to solicit your help. They are looking for archival
collectibles or medical memorabilia, such as surgical
instruments and antiquated medical equipment, that may be
borrowed to put on display during the 1OQih Celebration and
Walk-Through History Exhibit. This exhibit is being
professionally built by designers Bill Kreider and Drew Francis,
and coordinated by Sheryl Hawk of Public Affairs. It will be
open to the public in September during the Senior Horizons
and Nite Utes special events to be held in Agricultural Hall at
the Allentown Fairgrounds.
All items will be safeguarded and returned to you following ''"
exhibit. For more information, please contact Sheryl Hawk,
Public Affairs, at (610) 317-4816.

News from the Pool Trust
The Dorothy Rider Pool Health Care Trust is pleased to
announce the addition of Ronald C. Dendas as a program
officer primarily responsible for grant management for the Pool
Trust.
Prior to joining the Pool Trust, Mr. Dendas was executive
director of AIDSNET, the regional planning coalition and fiscal
agent for HIV/AIDS related services in a six-county area.
AIDSNET helped develop, network and fund not-for-profit
social service organizations providing care to people living with
or at risk to become infected with HIVIAIDS. He was
responsible for helping these agencies establish stronger fiscal
management practices and outcome-based services. Prior to
AIDSNET, Mr. Dendas was the executive director of the
Schuylkill County Drug and Alcohol Executive Commission.
A native of Nazareth, Pa., Mr. Dendas received a Bachelor (
Science degree in Criminal Justice from St. Anselm College ur
New Hampshire and a Master of Science in Human
Organization Science from Villanova University.
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Press Ganey Results for April, 1999

Congratulations!

In an effort to keep physicians informed of how they are rated
by patients in the Press Ganey reports, beginning with this
issue of Medical Staff Progress Notes, physician ratings will
be published each month. The Inpatient Monthly Report for
April, 1999 is as follows:
This Period Last Period
85.8
84.9
Overall Physician Rating
Time Physician spent with you
81.6
80.1
84.5
Physician concern questions/worries 85.6
Physician kept you informed
84.5
83.9
87.4.
Friendliness/courtesy of physician
89.0
Skill of physician
·
92.1
90.7

Kevin E. Glancy, MD, Division of Trauma-Surgical Critical
Care/General Surgery, was recenHy approved for
reappointment as a Fellow of the American College of
Emergency Physicians.

In addition to the above ratings, following are a number of
comments made by patients regarding their physicians:
~
~

~

(
~
~
)>
)>

~

~

)>
)>
)>
)>
)>

All nurses and Dr. Gertner were highly professional and
kind towards my baby and myself.
Dr. Jung and his assistant were wonderful. They
explained everything clearly and made me feel much more
at ease.
The anesthesia doctor and operating room nurses were
cheerful and kind. Explained everything to me. They
could not be any better. Just wonderful! They put me at
ease.
Anesthesia doctor was beyond excellent. Her name was
Serena.
Dr. Radio was excellent in my case during labor and
delivery.
Dr. Smolinski was just Super! He explained everything to
me and also made me laugh when it was tough to laugh.
Dr. Olex was great, tool
Dr. D'Angelo continues to exceed my expectations. Wish
all doctors would follow his personable, comforting, caring,
down-to-earth interaction with the patient.
Dr. Brett Godbout is excellent. He thoroughly answered
all questions in a way I could understand. He told me
what to expect after the operation and what I could hope
to accomplish.
Dr. Robert P. Marcincin is tops in his field, and his bedside
manner is excellent.
Dr. Gina Karess is a great person.
Dr. Joe Guzzo- wonderful, wonderful.
Dr. James Kintzel was very responsive to my needs and
did not hesitate to make me feel better.
Dr. Karper works very well with me. He is super.

Serena A Jung, MD, Department of Anesthesiology, was
recently certified by the American Board of Anesthesiology.
Larry N. Merkle, MD, Chief, Division of Endocrinology/
Metabolism, was elected Vice Chairman of the Pennsylvania
Diabetes Academy, an affiliate of The Foundation of the
Pennsylvania Medical Society since 1984, at the recent Board
of Directors meeting. In addition, he was recently honored by
the Lehigh Valley Chapter of the Amertcan Diabetes
Association at their Third Annual Dinner Dance and Silent
Auction held at the Allentown Hilton on April16.

Papers, Publications and Presentations
Wayne E. Dubov, MD, Division of Physical
Medicine/Rehabilitation, presented "Successful Alternatives to
Benzodiazepines for Agitation" at the recent Medical College of
Virginia's 23rd Annual Cognitive, Neuromedical and Behavioral
Aspects of Brain Injury Conference. The paper was coauthored by Peggy E. Showalter, MD, Department of
Psychiatry; Deborah N. Kimmel, MD, Division of Physical
Medicine/Rehabilitation, and Dr. Dubov.
In addition, Drs. Kimmel and Showalter co-authored two
articles which were presented as poster presentations at the
June meeting of the World Congress on Brain Injury held in
Quebec, Canada. The poster presentations included
"Alternative Medications for Agitation, Anxiety, Insomnia, and
Irritability Symptoms following Brain Injury," and "Beyond
Agitation: Psychiatric Diagnosis of Patients with Agitated
Symptoms Resulting from Brain Injury."
Mark A Gittleman, MD, Division of General Surgery, was an
invited speaker at the Texas Health Research lnstiMe for the
symposium, "Minimally Invasive Technologies: Medicine in the
21st Century," which was held on May 14 at Presbytertan
Hospital of Dallas in Dallas, Texas. Dr. Gittleman was also an
invited speaker at the 21st New York State Surgical
SymP.Qsium on May 22 in Cooperstown, New York. He
lecturlKI on "Image Guided Breast Biopsy."
(Continued on Page 10)
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(Continued from Page 9)
Larry R. Glazerrnan, MD, Division of Primary Obstetrics and
Gynecology, participated in a debate on "Hysterectomy vs.
Hysteroscopy for Abnormal Uterine Bleeding" at the 47th
annual clinical meeting of the American College of
Obstetricians and Gynecologists which was held May 19 in
Philadelphia.
William F.lobst, MD, Division of Rheumatology, had his
project abstract, "Rheumatology as a Longitudinal Curriculum,"
published in the spring edition of the MedEd News of the
Office of Educational Development at Harvard Medical School.
This project was the focus of Dr. lobst's endeavors as a
scholar in the Harvard Macy Institute Program for PhysicianEducators during 1998. He was invited to retum to the
program in 1999 as a faculty member. The program is
sponsored by Harvard Medical School and the Harvard
Graduate School of Education.
Masayuki Kazahaya, MD, Division of Ophthalmology, and
Glen L. Oliver, MD, Chief, Division of Ophthalmology, both
attended the Central Pennsylvania Retinal Society meeting on
May 7 in Hershey. Dr. Kazahaya presented a case report on
management of intraocular glass foreign body removed by
pars plana vitrectomy. Dr. Oliver presented a case report on
drainage of preretinal hemorrhages by YAG laser
photodisruption.
Thomas D. Meade, MD, Division of Orthopedic Surgery, was
an invited lecturer at a conference held in Bermuda sponsored
by the Rothman Institute and Biomet titled "Crucial Decisions
in Total Joint Arthroplasty and Sports Medicine." Dr. Meade
presented three talks including "Technical Pear1s in Performing
Anterior Cruciate Ligament Reconstructive Surgery, • "Clavicle
and AC Joint Injuries in Athletes Operative Options, • and "The
Lateral Approach to the Valgus Knee for the Recreational Total
Joint Surgeon."
Larry N. Merkle, MD, Chief, Division of Endocrinology/
Metabolism, authored an article, "Landmark Diabetes Studies
Make a Difference,• which was published in the June, 1999
issue of Pennsylvania Medicine.
Khawaja Azi Muddin, MD, colon and rectal surgery resident,
and lndru T. Khubchandani, MD, Division of Colon and
Rectal Surgery, co-authored the article, "Current Options in the
Surgical Management of Ulcerative Colitis," which was
published as the lead article in Volume 18 of the Indian
Journal of Coloproctology.

In addition, Dr. Muddin presented ·urocolonic Neoplasia:
Uncommon Entity - Difficult Managemenr at the American
Society of Colon and Rectal Surgeons meeting in May. This
paper was co-authored by Dr. Khubchandani, John J. Stasik,

MD, Chief, Division of Colon and Rectal Surgery; Lester
Rosen, MD, Associate Chief, Division of Colon and Rectal .
Surgery; and Robert D. Riether, MD, Colon and Rectal (
Surgery Residency Program Director.
·
Craig R. Reckard, MD, Chief, Section of Transplantation
Surgery, was an invited speaker at the American Society for
Histocompatibility and Immunogenetics (ASHI) Regional
Education Workshop that was held May 5-7 in Allentown. Dr.
Reckard spoke on various aspects of "The Clinical
Management of a Sensitized Patient. •

Upcoming Seminars, Conferences and
Meetings
LTACH Informational Sessions
Two Medical Staff informational sessions have been scheduled
to provide an overview of the long-term acute care hospital
(LTACH) that Good Shepherd Rehabilitation Hospital will own
and operate at Lehigh Valley Hospital.
The sessions will be held as follows:
Tuesday, July 13

~~~orium, Lehigh Valley Hospital, Cedar Crest & 1-78 (
Tuesday, July 20
6p.m.
Classroom 1, Lehigh Valley Hospital, Cedar Crest &1-78
Jane Dorval, MD, Chief, Division of Physical Medicine &
Rehabilitation; Stephen C. Matchett, MD, Division of
Pulmonary Medicine; and Linda Dean, LTACH Hospital
Operations, will provide the overview and be available to
answer questions.
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Medical Staff Progress Notes

Who's New
(

Medical Staff
Appointments
Keith R. Doram, MD
LVPG-Medicine
Lehigh Valley Hospital
Cedar Crest &1-78
P.O. Box689
Allentown, PA 18105-1556

(610) 402-8200
Fax: {610) 402-1675
Deparbnent of Medicine
Division of General Internal Medicine
Provisional Active
Site of Privileges: LVH & MHC
Tayyaba S. Jan, MD
(Solo practice)
7615 Tilghman Street
Fogelsville, PA 18051

(610) 366-9990
(

Deparbnent of Pediatrics
Division of General Pediatrics
Provisional Active
Site of Privileges: LVH & MHC
Michael J. Nlmeh, DO
Primary Care Associates in the LV, PC
1028 N. 19111 Street
Allentown, PA 18104-3762

(610) 437-1288
Fax: (610) 432-6517
Deparbnent of Medicine
Division of General Internal Medicine
Provisional Active
Site of Privileges: LVH & MHC
Janet L Osborne, MD
Lehigh Valley Women's Cancer Center
1611 Pond Road
Suite 101
Allentown, PA 18104-2256

(610) 366-8555
Fax: (61 0) 366-8550
Department of Obstetrics and Gynecology
Division of Gynecology
Section of Gynecologic Oncology
Provisional Active
Site of Privileges: MHC
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Steven J. Svabek, DO
Coordinated HeaHh Systems
2775 Schoenersville Road
Bethlehem, PA 18017-7326

(610) 861-8080
Fax: (610) 865-2761
Department of Surgery
Division of Orthopedic Surgery
Provisional Active
Site of Privileges: MHC
John B. Villeneuve, MD
Lehigh Valley Women's Cancer Center
1611 Pond Road
Suite 101
Allentown, PA 18104-2256

(610) 366-8555
Fax: (610) 366-8550
Department of Obstetrics and Gynecology
Division of Gynecology
Section of Gynecologic Oncology
Provisional Active
Site of Privileges: MHC

Appointment to Medical Staff Leadership Position
Lawrence W. Bardawll, MD
Associate Chief
Division of Gastroenterology
Keith R. Doram, MD
Chief
Division of General Internal Medicine
Robert Kricun, MD
Chairperson
Department of Radiology/Diagnostic Medical Imaging

Address Change
Nora A. Suggs, MD
1230 S. Cedar Crest Blvd., Suite 303
Allentown, PA 18103-6212

(610) 439-4108
Fax: (61 0) 435-5003

Practice and Address Changes
Mark C. Lester, MD
LVPG-Neurosurgery
1240 S. Cedar Crest Blvd., Suite 305
Allentown, PA 18103-6264

(61 0) 437-4911
Fax: (610) 820-5357
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Russell J. Rentler, MD
(Solo Practice)
6083 HamHton Blvd.
Wescosville, PA 18106-9767
(610) 530-7712
Fax: (610) 530-1921
Thomas J. Tachovsky, MD
Cancer Care Associates
830 Ostrum Street
Bethlehem, PA 18015
(610) 954-2140
Fax: (610) 954-3583

Status Changes
Arthur A. Altman, MD
Department of Pathology
Division of Clinical &Anatomic Pathology
From Provisional Active to Honorary
Russ S. Bergman, DMD
Department of Dentistry
Division of General Dentisby
From Provisional Associate to Provisional Active ·
Site of Privileges: LVH &MHC
Arnedeo DiEdwardo, DDS
Department of Dentistry
Division of General Dentisby
From Associate to Provisional Active
Site of Privileges: LVH & MHC
Martin L. Leymeister, DMD
Department of Dentisby
Division of General Dentistry
From Associate to Provisional Active
Site of Privileges: LVH & MHC
Brent M. Nicklscher, DO
Department of Medicine
Division of General Internal Medicine
From Provisional Active to Active
Site of Privileges: LVH &MHC
Lauri Passeri, DMD
Department of Dentistry
Division of General Dentistry
From Associate to Provisional Active
Site of Privileges: LVH & MHC

Gary G. Peters, DDS
DepartrnentofDentisby
Oivision of General Dentistry
From Associate to Provisional Active
Site of Privileges: LVH &MHC

Page 12

(

Joseph H. Schaffer, DDS
Department of Dentistry
Division of General Dentistry
From Associate to Provisional Active
Site of Privileges: LVH & MHC
Ruth Ann Spears, MD
Department of Family Practice
From Affiliate to Honorary
Thomas J. Tanzosh, DMD
Department of Dentistry
Division of General Dentisby
From Associate to Provisional Active
Site of Privileges: LVH &MHC
John C. Worsley, DMD
Department of Dentistry
Division of General Dentistry
From Associate to Provisional Active
Site of Privileges: LVH &MHC

(

Yelena M. Yermak, MD
Department of Psychiatry
From Division of Psychiatric Ambulatory Care/Adult Inpatient
Psychiatry
To Division of Consultation/Liaison Psychiatry
From Provisional Active to Active
Site of Privileges: LVH & MHC

Leave of Absence
Dennis W. Kean, MD
Department of Pediatrics
Division of General Pediatrics
From Active to Active/LOA
Site of Privileges: LVH & MHC

Resignations
Manuel H. Espinosa, MD
Department of Surgery
Division of General Surgery
Active

(
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Humberto J. Gonzalez, MD
Department of Psychiatry
Associate

Allied Health Professionals

Bruce M. Greenspan, MD
Department of Surgery
Division of Otolaryngology-Head &Neck Surgery
Associate

Jennifer M. Knights, PA·C
Physician Extender
Physician Assistant- PA-C
From: Theodore G. Phillips, MD- The Heart Care Group, PC
To: Thomas D. Meade, MD- Orthopaedic Associates of
Allentown

. Gary J. Heckenberger, DDS
Department of Dentistry
Division of General Dentistry
Associate

Change of Supervising Physician

Robert C. Hunsicker, MD
Department of Surgery
Division of Otolaryngology-Head & Neck Surgery
Associate
Gregory J. Menio, MD
Department of Surgery
Division of Orthopedic Surgery
Associate

(

Anthony F. Moscato, MD
Department of Medicine
Division of General Internal Medicine
Active
Glenn Moyer, MD
Department of Surgery
Division of Ophthalmology
Active
Lino A. Quilo, MD
Department of Emergency Medicine
Division of Emergency Medicine
Active
Timothy Scharle, MD
Department of Medicine
Division of General Internal Medicine
Associate
Melinda Toney, MD
Department of Family Practice
Active

(

Steward G. Wolf, MD
Department of Medicine
Division of General Internal Medicine

Emeritus Associate

Happy Fourth of July!

lEHI&IVAILEY
HOSPITAL

THERAPEUTICS AT A GLANCE
The following actions were taken at the May 1999 Therapeutics Committee Meeting -Clinical Pharmacy
Services -Joseph Ottinger, R.Ph., MS, MBA, Christopher Moore, R.Ph., James Sianis, Pharm.D.

Emesis Nemesis
Scoring guidelines (based on Hesketh
article) delineating the emetic potential
of various chemotherapy drugs and
combinations thereof (includes dosing
considerations related to these agents)
have been developed. Some recent
data and the latest consensus guidelines
from NCCN (National Comprehensive
Cancer Network), MASCC
(Multinational Association of
Supportive Care in Cancer), ASCO
(American Society of Clinical
Oncologists), and ASHP (American
Society of Health-System Pharmacists)
appear to support the use of oral
therapy for prophylaxis regimens in
those patients able to tolerate them.
This information has been utilized to
modify previously codified anti-emetic
therapy for certain prophylaxis
regimens; and the treatment of selected
"breakthrough"/"delayed" episodes of
nausea and vomiting.. The changes are
primarily related to the use of
ondansetron vs granisetron orally and to
reducing the intravenous doses of
ondansetron in these selected instances.
The following changes will be made to
the existing "Antineoplastic Agent
Order Sheet" when current supplies are
exhausted. In the interim, the
pharmacist will record the
modifications to the antiemetic
algorithm elaborated in the following
sections:
Sections C and D, Moderate
Emetogenic Potential class , level 3replace oral Granisetron lmg BID or
Granisetron 2 mg daily with oral

(

ondansetron 16 mg for each day of
chemotherapy.
Decrease the dose of IV ondansetron
to an 8 mg dose vs. the 16 mg dose
currently listed. All other
medications and their respective dosing
will remain the same.
Section E and F, High Emetogenic
Potential class, level 4&5-substitute
oral ondansetron 24 mg for each day
of chemotherapy for oral Granisetron
lmg BID or Granisetron 2mg daily.
Substitute IV ondansetron at a 16 mg
dose vs. the 24 mg dose currently
listed. All other medications and
their respective dosing will remain the
same.

In the Low Emetogenic Potential class
TREATMENT section, substitute oral
ondansetron 16mg daily for oral
Granisetron lmg BID or 2mg ~ly.
All other treatment choices will remain
unchanged.

(

Apply Sparingly
In order to streamline the selection of
topical steroid preparations and
eliminate unnecessary "calls", an
automatic substitution policy will be
adopted. The product selection process
was developed via the use of
vasoconstrictor assay stratification of
existing FDA-approved formulations.
After identifying the "potency"
classification of the topical product, a
formulary preparation of similar type
(e.g, ointment for ointment) will be
substituted as indicated below.
Relative Potency of Selected Topical
Corticosteroid Products as rated by
Vasoconstrictor Assay

(
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(

Formulary Substitution

Very High Potency
Augmented betamethasone d.ipropionate oint. 0.05%
Clobetasol propionate crJoint.
Diflorasone oint. 0.05%
Halobetasol propionate crJoint. 0.05%

High Potency
Amcinonide crJointO.l%
Augmented betamethasone d.iproprionate cr. 0.05%
Betamethasone diproprionate crJoint. 0.05%
Betamethasone valerate oint 0.1%
Desoximetasone crJoint. 0.25% crJoint.
Diflorasone diacetate crJoint. 0.05%
Fluocinolone acetonide cr. 0.2%
Fluocinonide crJoint. 0.05%
Halocinonide crJoint. 0.1%

Medium Potency

(

Betamethasone benzoate cr. 0.025%
Betamethasone valerate cr. 0.1%
Clocortolone pivalate cr. 0.1%
Desoximetasone cr. 0.05%
Fluocinolone acetonide crJoint. 0.025%
Flurandrenolide crJoint. 0.025%
"
0.05%
Fluticasone propionate cr. 0.05%
"
oint. 0.005%
Hydrocortisone butyrate oint 0.1%
Hydrocortisone valerate crJoint. 0.2%
Mometasone furoate crJoint. 0.1%
Triamcinolone acetonide crJoint. 0.025%

"
"
"

Clobetasol
0.05% crJoint.

$0.85/ gram
for both products

Fluocinonide
0.05% cr./oint.

$0.35/gram for
oint $0.06/gram
for cream

Triamcinolone
acetonide crJoint 0.1%

$0.01/gram for
cream
$0.06/gram for
oint.

0.1%
0.5%
0.5%

Low Potency
Aclometasone dipropionate crJoint. 0.05%
Desonide cr. 0.05%
Dexamethasone sodium phosphate cr. 0.1%
Fluocinolone acetonide cr. 0.01%
Hydrocortisone crJoint. lo/o-2.5%
"
acetate crJoint. O.So/o-1%

($)Cost/gram

Hydrocortisone 1%
crJoint.

$0.02/gram for cream
$0.04/gram for oint.

Application directions will be continued as per the original physician order.
All Formulary agents are also available in topical lotions for those application to those areas not
amenable to creams and ointments.
All orders related to Dermatology consults will NOT be automatically substituted, but will require
authorization from the prescriber.

(
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SangCya Oral Solution

ADRReports

The FDA has approved SangCya, a
modified cyclosporine suspension. The
product was given an AlB rating
compared with Neoral suspension,
indicating that the two products are
considered bioequivalent. This
preparation will be utilized in-hospital
for all Neoral oral solution orders.
Orders for other cyclosporine
formulations will be dispensed as
written.

ADR reporting continued to be fairly
consistent for the last two quarters of
1998. Total incidents were eighty-nine
for the third quarter and eighty-eight for
the fourth quarter. Phannacists and
Nurses supplied about 90% of the
reports. There was one death in the 3rd
quarter and two deaths in the 4th quarter,
where drug therapy may have
contributed to the patients demise.
Below are the particulars for these two
quarters.

(

3rd Quarter Data
Table 1: Adverse Reactions By Reporter

Reporter
Pharmacist
Nurse
X-Ray Technician
Physician
TOTAL

~ R~orts

Reports
61

68.5
22.5
6.8
2.2
100

20
6

..1.
89

(

Table 2: Adverse Reactions By Drug Category

Drug Category
# R~orts
Antibiotics
35
Contrast Dyes
10
Psych/Neurologic Agents
8
Narcotic Analgesics
7
Abciximab (ReoPro)/heparin!TPA 11
Dopamine
2
Cardiac
10

% Rc::ports
39.3
11.2

Other

.Q

TOTAL

89

il
100 .

Table 3: Probability

9.0
7.9
12.4

2.2
11.2

of Drug-Related Reactions

Probability
Doubtful.
Possible
Probable
Highly Probable
TOTAL

# Re,ports

%Reports

3
30

3.4
33.7
61.8

55
..1
89

.u

100

Table 4: Adverse Reaction Severity
Classification
Mild

Moderate
Severe
TOTAL

# R~orts

24
51
14
89

% Reoorts
27
57.3
15.7

100

(
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Fourth Quarter Data
Table 1: Adverse Reactions By Reporter

(

Reports

Reporter

%Reports
63.3
25.0
9.1

56

Pharmacist
Nurse
X-Ray Technician
Physician

.l

TOTAL

88

22

8

2.3

Table 2: Adverse Reactions By Drug Category
#Reports

Drug Category

% R.e.ports

38
Antibiotics
11
Contrast Dyes
Psych/Neurologic Agents
6
Narcotic Analgesics
4
13
Abciximab (ReoPro)/heparin!TPA
0
Dopamine

43.2

8

9.1
9.1

Cardiac
Other
TOTAL

~

12.5

6.8
4.5
14.8

88

Table 3: Probability of Drug-Related Reactions

(

Probability
Doubtful·
Possible
Probable
Highly Probable
TOTAL

#Reports
0
40
45
_1

~

Rej?orts

45.5
51.1
3;4

88

Table 4: Adverse Reaction Severity

Moderate

# Rej?orts
35
43

Severe
TOTAL

88

Classification
Mild

(

10

% R.e.ports
39.8
48.9
11.3

Most Comroon Agent
Conray (6)
Cefazolin (8)
Abciximab (2)

Page 1E

A 'Singulair' moment
Montelukast, a leukotriene antagonist, is
approved for the prophylaxis and
chronic treatment of asthma in adults
and pediatric patients ( ;;:: 6 years of
age), and it is available as a chewable
tablet for children. It can be taken
without regard to food and is
administered once daily. ADR
incidents and frequencies are similar to
zafrrlukast (Accolate). Due to potential
benefits in compliance, expanded
indications, and lack of food-drug
related absorption issues this agent will
supplant zafirlukast on the Drug
Formulary. Accolate orders for 20 mg
BID will automatically be substituted
with montelukast 1Omg daily unless
patients have had a documented
'allergic' reaction to this product.

Fast Track AdditionsMay
1bree "product extension" preparations
were approved during this period. The
extended release formulations of
metoprolol (Toprol XL) and glipizide
(Glucotrol XL) were added along with
the "Diskus" inhalation system for
Serevent. The Formulary will contain
both the current MDI and ''Diskus"
delivery systems for Serevent until
further notice.
Federal EPA directives will require use
of non-fluoro/chloro-carbon propellants
for all :MOl's at some 1mdetermined
time. Several of the companies have
developed insuffiation devices (Glaxo;
Merck) while Schering-Key has opted to
modify its propellant system.
The "Diskus" device delivers the active
drug via an inhalation powder. In the

case of Serevent products, two "sprays"
of the MDI product provide an
equivalent dose (i.e., 50 meg) to one
insuftlation of the "Diskus".

(

.

(
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Transfusion Medicine -Informed Consent
Pennsylvania Law Act 135, enacted January, 1997, requires that a separate informed consent be obtained from patients
who are about to undergo planned or elective transfusion of blood or blood components.

Informed consent is the process of a physician communicating with a patient about a proposed procedure or treatment.
Documentation of this should be done in the patient's chart. The minimum elements of this informed consent process
include:
1. Patient should be informed of the reason for transfusion, i.e., purpose and the anticipated effect or benefit.
2. Patient should be provided altemative(s) to transfusion.
3. Patient should be made aware of the risks of transfusion.
(

The permission to be transfused must be obtained by a physician who has ordered the transfusion or designee. To assist
you with this process, the following information will be available on all nursing units: 1) Physician Information Sheet with the
current known risk factors and the expected incidence, 2) Patient Information Sheet (English and Spanish), and 3) Consent
Form/Refusal Form.
For a single admission, the consent needs to be obtained one time. However, when a patient is chronically transfused, the
consent, once obtained, is valid for one year. Refer to the Transfusion Consent Policy (AD 6301.00) which is attached on
Pages 21-24.
Copies of the revised form, MRD-31, are available from Consolidated Graphics using a Pic N Pac requisition form (MM-35).
For your information, a copy of MRD-31 is attached on Pages 25-30.
If you have any questions, please contact BaJa B. Carver, MD, Medical Director, Transfusion Medicine, at (610) 402-8142 or
beeper 3433.
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POLICY NO:. AD 6301.00
t"'

SUBJECT:
EFFECTIVE DATE:

(

Transfusion Consent
November 1997

AREAS AFFECTED: All Departments
PAGE:

I.

I of 4

POLICY
It is essential that a transfusion consent form be obtained from all patients who are
capable of giving consent or from a person authorized to consent on the patient's behalf
prior to the patient receiving blood. If possible, this consent should be obtained in the
physician's office prior to admission.
Blood and blood products applicable to this policy include whole blood, packed red blood
cells, fresh frozen plasma, platelets and cryoprecipitate. Consent must be obtained for the
· transfusion of autologous blood; however, it is not needed for autotransfusion of salvaged
blood. Transfusion consent/refusal is not needed for the administration of Factor VITI,
Factor IX, Albumin, Hepatitis B lmmWle Globulin, or Intravenous Gamma Globulin
(IGIV).
If an emergency exists, consent is not required to transfuse blood to the patient at that
time, however, a reasonable effort should be made to obtain consent in all cases. If
consent is unable to be obtained for any reason; the patient's medical record should state,
in detail, the efforts pursued, the nature of the threat to life or health including its
immediacy and magnitude. Once the emergency subsides and additional blood is needed,
consent must be obtained for any additional blood or blood products.

(

n.

SCOPE
Hospital Personnel

m.

DEFINITIONS
A.

IV.

Hospital Personnel - includes, but is not limited to, all employees, medical staff,
allied health professional staff, students, volunteers, and others engaged in any
activities at the hospital, excludini patients and visitors (JCAHO).

PRQCEDIJRE
Rcsponsibilizy

Action
A.

(

The policies and procedures outlined in the Consent
Administrative Policy Number 2100.00 apply to the
Blood Transfusion Consent.

Physician

Page 2:
Policy No: AD 6301.00
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(
Action

Responsibility

B.

Transfusion consent'Refusal Form will be obtained
by the physician who has ordered the transfusion or
his/her designee. The individual obtaining consent
should explain the risks, complications, benefits and
alternatives to transfusion as outlined in the Patient
Information for Blood Transfusion Sheet and the
physician Information for Blood Transfusion Sheet.

Physician

C.

The signature of a witness may be obtained. The
witness is witnessing the patient's signature only.

Physician/Nurse

·n.

If the patient is unable to sign because of physical
or mental incompetence or the patient is a minor,
consent must be obtained from the person
authorized to consent on behalf of the patient.

Physician

In some cases, it may be necessary to secure consent ·
via the telephone. The consent procedure must be
heard by one person other than the physician. The
consent form should indicate that it is a telphone
consent and the person who gave consent. The
person listening to the conversation will sign the
witness line.

Physician/Nurse

The consent/refusal for transfusion of blood and/or
blood products must be signed by the patient prior
to receiving blood and/or blood products. It is
preferable to have the consent/refusal for
transfusion signed before a type and cross match for
blood is ordered. However, blood may be drawn for
a type and cross match whether or not the consent is
known to be signed.

Physician

The consent form should ideally be signed in the
physician's office when discussing the surgical
procedure and the possible need for blood. When
the consent form is signed in the physician's office,
it is to be considered valid for 60 days prior to
admission to the hospital.

Physician

E.

. F.

G.

(

(
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Action

(

V.
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Responsibi1ity

H.

The consent form must be signed prior to sedating
the patient.

Physician

I.

During a single admission, the consent for blood
transfusion needs to be signed one time.

Physician

J.

When used in the outpatient settings, the Blood
Transfusion consent form should be considered
valid for one year.

Nurse!Administrative
Director

K.

Prior to surgery, when a patient has had a type and
cross match for blood, and the consent/refusal form
has not been signed the patient will not be sent to
the operating room until consent has been obtained.

Nursing

L.

If the patient is going for an operative procedure
and the attending physician does not feel it
necessary to order a type and cross match for blood
and the necessity for blood is not foreseen, a
consent/refusal form for transfusion is not
necessary.

Physician

ATTACHMENTS
A- Consent/Refusal for Transfusion of Blood and/or Blood Products (MR.D-31)
Physician Infonna.tion for Blood Transfusion
Patient Information for Blood Transfusion

VI.

DISTRIBIITION
Administrative Policy Manual

vn.
President & CEO
Title
-=~~!::L~~~~~;t=~=-

..

President. Medica] Staff
Title

Sr. Vice President. Clinical Services
Title

/l).sojq;
Date

/1} 3o/ 91
Date

1,J 3ol CjJ
Date
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VIII. POLICY BESPONSWILIIY:
Sr. Vice President, Clinical Services

IX.
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IN COORDINATION Wim:

(

Transfusion Review Committee

BEFEBENCES
NIA

X.

REVISION
Hospital reserves the right unilaterally to revise, modify, review, rescind or alter the tenns
and conditions of this policy within the constraints of the law, by giving reasonable
notice.

XI.

OTUERS
NIA

XII.

DATES
Origination:

12/90

Last Review:

11/97

Next Review:

11/2000

(

0

0

0

0

0
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Consent/Refos_al for Transfusion ofBlood
and/or Blood Products

Physician Information for Blood Transfusion
With the advent of increased medical and legal risks for patients receiving blood transfusions, it is essential that physicians ordering
blood transfusions thoroughly advise patients of the potential risks involved. In emergency situations where the patient cannot
complete the fonn, the treatment note in the medical record indicating the number of units transfused and reason needed should
suffice as lnfonned Consent cannot be secured after the fact. Once the emergency situation concludes, but the patient requires
additional units of blood, consent should be obtained.
Physicians obtaining lnfonned Consent should set aside ample time to meet with the patient and/or authorized person to advise
them of risks and alternatives, and answer any questions prior to obtaining the signature on the consent fonn.

The accompanying Patient Information Sheet for Blood Transfusion should be given to the patient for their review. The
risks listed should be discussed with the patient and/or authorized person along with any additional risks that you feel
should be addressed. In describing and explaining the risks of blood transfusion, the information contained below may be
useful. It should be noted that the incidence, as pointed out below, is a very close approximation from the literature as it
exists today. We will update these if significant changes take place in the future.

0

Patient and/or authorized person should be infonned of the following infonnation relating to the risks of blood transfusion:
• The possibility of needing a transfusion.
• Approximate number of transfusions that can be expected during the course of the medical treatment.
• Type of blood used and risk of each type.
• An understanding of what medical action is recommended.
• The associated risks and benefits of transfusion.
• Alternative methods of therapy available including pre-deposit autologous transfusion, intraoperative salvage,
isovolemic hemodilution, and directed donation.
• The possible consequences of not receiving the recommended therapy.
• An opportunity for the patient and/or authorized person to ask questions.

(_)

0

Lastly, have the patient and/or authorized person sign the consent fonn if he I she decides to accept or refuse the transfusion.
The risks may be immediate or long tenn, and include both immunologic and infectious disease consequences. Areas of particular
importance are:
• Hemolytic transfusion reaction. Incidence is 1 in 25,000 with a fatal incidence being 1 in 1,000,000.
• Transmission of infectious diseases. Incidence for: HIV infection, 1 in 500,000; Hepatitis C, 1 in 100,000;
Hepatitis B, 1 in 60,000; HTLV, 1 in 600,000.
• Febrile reactions. Incidence 1 in 100.
• Allergic reaction. Incidence 1 in 300.
~ Circulatory overload reactions.
• Bacterial contamination, e.g. Yersinia Enterocolitica < 1 in 1,000,000 for red cells; 1 in 10,000 for platelets.
• Immune problems such as antibody fonnation.

(

In regards to autologous transfusion as an alternative to •community blood" please explain this option and clearly infonn patients
that for elective surgery, this is an acceptable and desirable alternative if the patient meets the screening requirements and is a
suitable candidate. You, in concert with the Blood Bank Medical Director, make that decision.

)

.

At Lehigh Valley Health Network directed donations and autologous donations are offered as alternatives to volunteer donor blood.
The directed blood option, although available, is generally not encouraged by transfusion medicine specialists because the literature
has not shown that this is a significantly safer alternative to community blood.
MRD-31

Rev. 5/99

PHYSICIAN COPY
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Consent/Refus_al for Transfusion ofBlood
and/or Blood PrOducts

Patient Information Sheet for Blood Transfusion
What Is It?
A blood transfusion is a treatment where someone receives blood or a part of blood from a donor. A donor is a person who gives
some of their own blood to help another person who needs it. A person could receive blood for any of these reasons:
• Blood lost during surgery
• Blood clotting problems
• Shock

• Illness which does not allow your
body to make its own blood cells
• Injury

When blood is taken from a donor, it is whole blood. Whole blood can be separated into parts which may be used to treat special
blood problems. These blood parts or components, can be red blood cells (RBC's), plasma, platelets, and cryoprecipitate.

Blood Types
The most important blood group is ABO, which is divided into four types: 0, A, B, and AB. Each person is born with one of these
blood types. The Rh factor is also one of the blood types. Your blood can either be Rh (+) or Rh (-). Both these factors (blood
types and Rh) are used when matching your need for blood to a donor's blood.

Safety of Blood

(

There is no guarantee that the blood is 100% risk free. Before you receive donated blood, a sample of your blood will be tested to
match the donor's blood. Although these measures are taken, bear in mind that a small group of patients may still react to the
donor's blood. These symptoms may include: hives, fever, chills, breathing problems, itching, back pain, and wheezing. You will be
carefully watched and cared for should you have a reaction.
There is a slight risk of passing an illness or disease on to you, and problems can occur in the processing, preparing and giving of
the blood. The major diseases known to be passed through the blood are viral diseases such as Hepatitis B, Hepatitis C,
HIV(AIDS), Human T-cell Leukemia and Cytomegalovirus. There have also been rare cases of syphilis, malaria, and Hepatitis A
reported. In these cases, the person who donates the blood is carrying the disease at the time of the blood donation. Please bear
in mind that every effort is made to minimize these risks. These efforts include: careful screening of donors through medical
history, and testing for the specific diseases. If the presence of a disease is detected in the blood, the blood is not used.
Viral disease detection cannot be 100%. One reason for this is the "window of time" between getting infected and being able to
detect the presence of disease. During this "window of time", the donor may feel normal, all tests on the donor are negative, but the
donor is a "silent carrier" of the virus.
The safest blood you can receive is your own (called Autologous Donation). For this and other alternatives, ask your doctor.

Blood Transfusion Procedure
Before

You will be asked to sign a consent form. Then an intravenous (IV) will be started. A large needle is used because it
allows the blood to infuse smoothly and prevents damage to the blood cells.

During

You will be watched closely. Your temperature, pulse, blood pressure and IV site will be checked at the start of your blood
transfusion as well as during the process.
Many safety measures are taken to be sure you receive the right blood unit. The numbers on your name bracelet will be
checked to be sure they match the numbers on the blood unit.
PLEASE NOTE! Inform your nurse if at any time during the transfusion you have any of the following symptoms:
• Fever
• Chills/shaking
• Upset stomach/vomiting

(
After:

MRD-31

• Headache
• Back or chest pain
• Trouble breathing

• Itching
• Tingling in your fingers
• Muscle cramps

When your blood transfusion is complete, your doctor may order a lab test to see if the blood has helped you. You may ?r
may not have the IV removed at this time. You also will have your blood pressure, pulse and temperature checked at thrs
time.
(Reverse Side in Spanish)
Rev. 5/99

PATIENT COPY
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Informacion para el Paciente sobre Transfusion de· Sangre
QueEs

Una transfusion es un tratamineto donde una persona recibe sangre o una parte de Ia sangre del cuerpo de un donante. Un
donante es una persona que da su sangre para ayudar a otra persona que lo necesite. Una persona puede recibir sangre por
cualquiera de las siguientes razones:
• Pimlida de sangre durante cirugia
• Problemas de coagulacion sanguinea
• Shock

• Enfermedad que no permite que su
cuerpo produzca celulas sanguineas
• Heridas

Cuando Ia sangre se adquiere de un donante es sangre entera. La sangre entera se puede separar en partes que pueden ser
usadas para el tratamiento de problemas sanguineos. Estas partes o compuestos pueden ser las celulas rojas (RBC), plasma,
plaquetas o crioprecipitantes.

Tipos de Sangre
El grupo mas importante es ABO, que esta dividido en cuatro tipos: 0, A, 8 y AB. Cada persona nace con uno de estos tipos de
sangre. El factor Rh es algo que todo el mundo tiene en su sangre. Su sangre puede ser Rh positive(+) o negative(-). Ambas
cosas el tipo de sangre y el factor Rh son necesarios para conseguir un donante compatible con su sangre.

Seguridad de Ia Sangre
No hay ninguna garantia que Ia sangre es 100% libre de riesgo. Antes de recibir sangre donada, se probara su sangre para
asegurar que sea compatible con Ia del donante. Aunque se toman estas medidas, es necesario que tenga en mente que un grupo
pequeiio de pacientes pueden tener reacciones a Ia sangre donada. Estes sintomas pueden incluir escalofrios, problemr
respiratorios, alergias en Ia piel, picor y dolor de espalda. Usted sera mantenido bajo observaci6n y se le atendera si desa1'111.
alguna reaccion.
Hay una pequeiia posibilidad de que se le transmita alguna enfermad, pueden ocurrir problemas en el proceso de preparar y
administrar Ia sangre. Las enfermedades mas serias que pueden ser transmitidas a traves de Ia sangre son enfermedades virales
tales como Ia Hepatitis B, Hepatitis C, HIV(AIDS), Leucemia Humana Tipo T y citomegalovirus. Se han reportado cases de sifilis,
malaria y Hepatitis A. En estos casos, Ia persona que dona Ia sangre padece Ia enfermedad en el momenta de Ia donaci6n. Por
favor recuerde que se hace el mayor esfuerzo posible para reducir los riesgos. Estos esfuerzos incluyen: evaluacion cuidadosa de
los donantes a traves de su historial medico y se hacen pruebas para diagnosticar enfermedades especificas. Si se detecta Ia
presencia de alguna de estas enfermedades, no se usa esta sangre.
La detecci6n de enfermedades virales noes siempre 100%. Una razon es el tiempo necesario para una persona infectarse y el
memento de detectar Ia enfermedad. Durante este tiempo el donante puede sentirse normal, todos los resultados son negativos
pero el donante puede ser el transmisor silencioso del virus.
La sangre mas segura que usted puede recibir es Ia suya (donaci6n autologa). Para esta altemativa, consulte con su medico.

Procedimiento
Antes:

Se le pedira que firme una forma de autorizacion. Se le comenzara una linea intravenosa (IV). Se usara una aguja
grande para que Ia sangre fluya con suavidad y para prevenir daiios a las celulas sanguineas.

Durante: Sera observado cuidadosamente. Su temperatura, pulse, presion sanguinea y localizaci6n del IV se revisaran al
comenzar Ia transfusion y durante el proceso.

Se usan medidas de seguridad para asegurar que reciba Ia unidad de sangre correcta. Los numeros en el brazalete con
su nombre se verificaran para asegurar que sean los mismos en Ia unidad de sangre.
TOME NOTAl Notifique a Ia enfermera si durante Ia transfusion usted ha tenido alguno de estos sintomas:
• Fiebre
• Escalofrios
• Est6mago descompuesto/vomitos

• ·Dolor de cabeza
• Dolor de espalda o del pecho
• Problemas respiratorios

• Picor
• Calambre en los dedos, manes
• Calambre en los dedos o musculares

(

Despues: Cuando Ia transfusion este completa su medico ordenara una prueba de laboratorio para ver si Ia sangre le ha ayudado.
Puede o no que le remuevan eiiV. Se le tomara el pulso, Ia presion sanguinea y Ia temperatura.
PAGE 2- SIDE 2 OF 2
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CONSENT
FOR TRANSFUSION OF BLOOD
AND/OR BLOOD PRODUCTS

0

1.

I have been informed by Dr.
that circumstanc1
may arise during inpatient/outpatient treatment at Lehigh Valley Health Network that may make it necessary
administer blood and/or blood products to me. I have reviewed the "Patient Information Sheet for Blood Transfusio
information.

2.

The risks and adverse consequences of accepting blood and/or blood product transfusions as well as the risks ar
consequences of refusing to accept blood and/or blood product transfusions have been explained to me.

3.

I understand that there are no warranties of any kind, express or implied, of merchantability, fitness, quality
otherwise made in connection with the transfusion of blood and/or blood products.

4.

I acknowledge that I have been given an opportunity to ask any questions that I might have concerning the risks

1

1

I hereby consent to permitting authorized members of the hospital staff to administer blood and/or blood products and sue
additional transfusions as may be deemed advisable by my doctor.

()

0
AM
P.M
Witness to Signature

Signature of Patient

Second Witness to Signature (two witnesses are required if Patient
signs by making a mark "X'1

If Patient is a minor or is incapable of consenting, signature of nearest
relative or legal guardian, or one legally entitled to consent

Time

Relationship

1 have discussed the procedure as outlined above with the patient or the patient's authorized representative and answerec
all questions.

A.M.
P.M.
Signature of Attending Physician

MRD-31

Rev. 5199

Date

CHART COPY

Time
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(

REFUSAL
FOR TRANSFUSION OF BLOOD
AND/OR BLOOD PRODUCTS

I,
, refuse to consent to the transfusion of
blood and/or blood products. I acknowledge that I have been informed and fully understand the risks and dangers, which
may or can result from this refusal. I further understand that this refusal will probably result in adverse consequences
including death.
'
I release the physicians, Lehigh Valley Health Network, its employees, agents and representatives from any and all
liability which could occur as a result of this refusal.

(

A.M.
P.M.
Witness to Signature

Signature of Patient

Second Witness to Signature (two witnesses are required if Patient
signs by making a mark "X'1

If Patient is a minor or is incapable of consenting, signature of nearest
relative or legal guardian, or one legally entitled to consent

Time

Relationship

PHYSICIAN'S CERTIFICATION: I have discussed the information outlined above with the Patient/Authorized Person and
answered all his/her questions. Following our discussion, the Patient/Authorized Person signed this Form in my
presence. It is my opinion that the Patient/Authorized Person understood all of the matters discussed on this date.

(
AM.
P.M.
Signature of Attending Physician

MRD-31

Rev. 5/99

Date

Time
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CRITICAL I CALLBACK LIMITS

(

(

AFB Smear

Any Positive

Ammonia

> 100

umoi/L

Amylase

> 300

U/L

Bilirubin

> 15.0

mg/dL
Call all outpatient
neonate bilirubins,
(NBIL)

Blood Culture

Any Positive

Calcium
i-Calc

< 6.5
< 3.3

> 12.0
> 6.5

mg/dL

Chloride

< 75

> 125

mEq/L

C02 content

< 15

>40

mEq/L

Creatinine

> 5.0

mg/dL

CSF Protein

> 75

mg/dL

>400

mg/dL

CSF Glucose

<40

CSF Gram Stain

Any Positive

Drugs, Therapeutic

Above Therapeutic
Range

Digoxin, >2.0
Dilahtin, >20.0
Theophylline, >20.0
Lithium, >1.2

> 750

mg/dL

Trough> 2.0
Peak > 12.0

ug/mL

(In Chemistry)
Fibrinogen

<75

Gentamicin

(

Glucose

<40

>400

newborn< 30, mg/dL

Hematocrit

< 25

>55

neonate <27 >75,%

Hemoglobin

< 8.0

> 20.0

neonate <9.0, >25.0
g/dL

>4.0

mmoi/L

Lactate
Magnesium

< 1.0

> 5.0

mg/dL

Osmolality

<250

> 325

mOs/kg
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CRITICAL I CALLBACK LIMITS

p02

< 60

pC02

< 20

> 60

pH

< 7.20

> 7.55

Phenytoin

(

mmHg
mmHg

> 20

ug/ml

Phosphorus

< 2.0

> 7.0

mg/dl

Platelets

<50
(1st time only)

> 750

thousand/ul

Potassium

< 3.0

> 6.0

newborn > 8.0,
mEq/L

PT

> 30.0

seconds

PTT

> 100.0

seconds

> 155

mEq/L

> 13.0

ug/dl

Sodium

< 120

T4
Tobramycin

Trough> 2.0
Peak > 12.0

Troponin I
TSH

> 2.0
(ER or 1st elevation)
<0.03

ug/ml
ng/ml
ulU/mL

Urea Nitrogen

> 100

newborn > 50, mg/dl

Uric Acid

> 13.0

mg/dl

> 20.0

thousand/ul

WBC

ANC < 1.5
(1st time only)

(
x:\lab\wp8\coffman\critauto.cht
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Cedar Crest & l-i8
Post Office Box 689
Allentown, Pennsylvania 18105-1 ;)6
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HEALTH NETWORK

June 17, 1999
Dear Physician Practice Healthcare Provider,
I wanted to make you aware of a new program, which is coming to the Lehigh
Valley. Lehigh Valley Hospital and Health Network is bringing The Chronic
Disease Self-Management Program to the Lehigh Valley for community
members who live with chronic conditions. This is the only program of its kind on
the region.
The program is a course given two and a half hours, once a week, for seven
weeks, in community settings such as senior centers, churches, libraries and
hospitals. People with different chronic health problems attend the course
together. Courses are facilitated by two trained leaders, one or both of whom are
non-health professionals with a chronic disease themselves.

(
Subjects covered include: 1) techniques to deal with problems such as
frustration, fatigue, pain and isolation, 2) appropriate exercise for maintaining and
improving strength, flexibility, and endurance, 3) appropriate use of medications,
4) communicating effectively with family, friends, and health professionals, 5)
nutrition, and, 6) use of community resources. Each participant in the course
receives a copy of the companion book, Living A Healthy Life With Chronic
Conditions, and an audio relaxation tape, Time for Healing.
The Self-Management Course will not conflict with existing programs or
treatment. It is designed to enhance regular treatment and disease -specific
education such as Better Breathers, cardiac rehabilitation, or diabetes instruction.
In addition, many people have more than one chronic condition. The program is
especially helpful for these people, as it gives them the skills to coordinate all
things needed to manage their health, as well as to help them keep active in their
lives.
I am in search of volunteer non-professional persons who are successfully
managing a chronic condition and are interested in participating in the program
as a facilitator. If you are aware of any persons who fit this description, please
refer them to me and I will arrange for them to attend the trainer class. It is
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expected the trainer class will be held in September with the first course for
participants to follow.

(

Please look for more information regarding the first course in the near future.
There will be a cost to the participant for attending the course. I am investigating
reimbursement for this cost from insurance carriers. I have included a summary
sheet with additional information about the Chronic Disease Self-Management
Course. If you have further questions, please do not hesitate to contact me at
610-402-5015, or email Wendy.Robb@LVH.com.
I look forward to this exciting and unique opportunity to assist our community
members with chronic conditions. Thank you for your time and consideration.

Sincerely,

v~~·

Wendy J. Robb, RN, MSN,
Chronic Disease Coordinator

(

X:msword\iqu\caremngmnt\wendy\CDSMPitr
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(

Chronic Disease Self-Management
Program
The Chronic Disease Self-Management Program is a course given two and a half
hours, once a week, for seven weeks, in community settings such as senior
centers, churches, libraries and hospitals. People with different chronic health
problems attend the course together. Courses are facilitated by two trained
leaders, one or both of whom are non-health professionals with a chronic disease
themselves.
Subjects covered include:
~ Techniques to deal with problems such as frustration, fatigue, pain and
isolation
~ Appropriate exercise for maintaining and improving strength, flexibility,
and endurance
~ Appropriate use of medications
~ Communicating effectively with family, friends, and health
professionals
~ Nutrition
~ Use of community resources

(

Each participant in the course receives a copy of the companion book, Living A
Healthy Life With Chronic Conditions, and an audio relaxation tape, Time for
Healing.
The Self-Management Course will not conflict with existing programs or
treatment. It is designed to enhance regular treatment and disease-specific
education such as Better Breathers, cardiac rehabilitation, or diabetes instruction.
In addition, many people have more than one chronic condition. The program is
especially helpful for these people, as it gives them the skills to coordinate all
things needed to manage their health, as well as to help them keep active in their
lives.

How was the Program developed?
The Division of Family and Community Medicine in the School of Medicine at
Stanford University received a five year research grant from the federal Agency
for Health Care Research and Policy and the State of California Tobacco Related
Diseases Office. The purpose of the research was to develop and evaluate,
through a randomized controlled trial, a community-based self-management
program that assists people with chronic illness. The study was completed in

1996.

(
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The research project had several investigators: Halsted Holman, MD, Stanford
Professor of Medicine; Kate Lorig, DrPH, Stanford Associate Professor of
Medicine; David Sobel, MD, Regional Director of Patient Education for the
Northern California Kaiser Permanente Medical Care Program; Albert Bandura,
PhD, Stanford Professor of Psychology; and Byron Brown, Jr, PhD, Stanford
Professor of Health Research and Policy. The Program was written by Dr. Lorig,
Virginia Gonzalez, MPH, and Diana Laurent, MPH, all of the Stanford Patient
Education Research Center. Ms. Gonzalez and Ms. Laurent also served as
integral members of the research team.

(

The process of the course was based on the experience of the investigators and
others with self-efficacy, the confidence that one has that he or she can master a
new skill or affect one's own health. The content of the course was the result of
focus groups with people with chronic disease, in which the participants
discussed which content areas were the most important for them.

How was the Program evaluated?
Over 1,200 people with heart disease, lung disease, stroke, or arthritis
participated in a randomized, controlled test of the Program, and were followed
for up to three years. Researchers looked for changes in many areas: health
status (disability, social/role limitations, pain and physical discomfort,
energy/fatigue, shortness of breath, psychological well-being/distress,
depression, health distress, self-rated general health), health care utilization
(visits to physicians, visits to emergency department, hospital stays, and nights in
hospital), self-efficacy (confidence to perform self-management behaviors,
confidence to manage disease in general, confidence to achieve outcomes), and
self-management behaviors (exercise, cognitive symptom management, mental
stress management/relaxation, use of community resources, communication with
physician, and advance directives).

What were the results?
Subjects who took the Program, when compared t those who did not,
demonstrated significant improvements in exercise, cognitive symptom
management, communication with physicians, self-reported general health,
health distress, fatigue, disability, and social/role activities limitations. They also
spent fewer days in the hospital, and there was also a trend toward fewer
outpatient visits and hospitalizations. These data yield a cost to savings ratio of
approximately 10:1. Many of these results persist for as long as three years.
For more information related to outcomes, please refer to the following article: Lorig, KR, et al. (1999). Evidence
Suggesting That a Chronic Disease Self-Management program Can Improve health Status While Reducing
Hospitalization: A Randomized Trial, Medical Care, 37(1), 5-14.

For additional information, please contact Wendy Robb, Chronic
Disease Coordinator, at 610-402-5015.

(
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MEDICAL STAFF OFFICERS
President
President-elect
Past President
Secretary
Treasurer
CHIEF MEDICAL OFFICER

David M. Caccese, MD
Edward M. Mullin, Jr., MD
Robert X. Murphy, Jr., MD
John J. Shane, MD
John J. Shane, MD

111/99- 12/31/2000
111/99 -12/31/2000
111199 -12/3112000
7/1/99 - 6/30/2000
7/1199 - 6/30/2000

Robert J. Laskowski, MD

Department of Anesthesiology

(

Alphonse A. Maffeo, MD, Chairperson
Domenico Falcone, MD, Vice Chairperson (MHC)
Karen A. Bretz, MD, Vice Chairperson for Quality Assurance
Thomas M. McLoughlin, Jr., MD, Vice Chairperson for Education and Research
Division of Cardiac Anesthesia
Division of Pain Management

Thomas M. McLoughlin, Jr., MD, Chief
Bruce D. Nicholson, MD, Chief

Department of Dentistry
Eric J. Marsh, DMD, Chairperson
S. Clark Woodruff, DMD, Vice Chairperson (MHC)
Scott A. Gradwell, DMD, Vice Chairperson (LVH)
Charles J. Incalcaterra, DMD, Residency Program Director (LVH)
Russ S. Bergman, DMD, Residency Program Director (MHC)
Dominic P. Lu, DDS, Director of Dental Externship Education
Division of Endodontics
Division of General Dentistry
Division of Orthodontics
Division of Pediatric Dentistry
Division of Periodontics
Division of Prosthodontics

(
Division of Special Care

Mark R. Eisner, DMD, Chief
Charles A. Kosteva, DDS, Chief (LVH)
Gary G. Peters, DDS, Chief (MHC)
Sara C. Karabasz, DMD, Chief
Marsha A. Gordon, DDS, Chief
Scott A. Gradwell, DMD, Chief (LVH)
Ann K. Astolfi, DMD, Chief (MHC)
John D. Karabasz, DMD, Chief (LVH)
Bernard D. Servagno, DMD, Chief (MHC)
Russel S. Bleiler, DDS, Chief
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Department of Emergency Medicine
Michael S. Weinstock, MD, Chairperson
RichardS. MacKenzie, MD, Vice Chairperson
Brian A. Nester, DO, Associate Vice Chair (MHC)
Alexander M. Rosenau, DO, Associate Vice Chair/Practice Management
Charles C. Worrilow, MD, Director, Education
Michael B. Heller, MD, Residency Program Director
Division of Emergency Medicine
Division of Prehospital Emergency
Medical Services

(

MichaelS. Weinstock, MD, Chief
. John F. McCarthy, DO, Chief

Department of Family Practice
William L. Miller, MD, Chairperson
Julie A. Dostal, MD, Vice Chairperson (LVH)
Dale M. Weisman, MD, Vice Chairperson (MHC)
William L. Miller, MD, Residency Program Director
Karla N. Noel, MD, Chief Resident
Division of Occupational Medicine
Division of Home Care

Carmine J. Pellosie, DO, Chief
Fred D. Fister, MD, Chief

Department of Medicine
John P. Fitzgibbons, MD, Chairperson
Jonathan H. Munves, MD, Vice Chairperson (MHC)
Richard H. Snyder, MD, Vice Chairperson (LVH)
Richard H. Snyder, MD, Residency Program Director
Joseph A. Candio, MD, Chief for Clinical Practice
Larry N. Merkle, MD, Student Mentor
Zubina Mawji, MD, Chief Medical Resident
Division of Allergy
Division of Cardiology

Division of Dermatology
Division of Endocrinology/Metabolism
Division of Gastroenterology

Division of General Internal Medicine
Division of Geriatrics
Division of Hematology/Medical Oncology
Division of Infectious Diseases
Division of Nephrology

Howard A. Israel, MD, Chief
D. Lynn Morris, MD, Chief
Norman H. Marcus, MD, Associate Chief (LVH)
Robert H. Biggs, DO, Associate Chief (MHC)
Arthur C. Sosis, MD, Chief
Larry N. Merkle, MD, Chief
Mohammad I. Arastu, MD, Associate Chief (MHC)
Carl F. D'Angelo, MD, Chief
Lawrence W. Bardawil, MD, Associate Chief (LVH)
Frederic A. Stelzer, MD, Associate Chief (MHC)
Keith R. Doram, MD, Chief
Jonathan H. Munves, MD, Associate Chief (MHC)
Francis A. Salerno, MD, Chief
David P. Carney, MD, Associate Chief
Gregory R. Harper, MD, PhD, Chief
Luther V. Rhodes III, MD, Chief
Jeffrey A. Jahre, MD, Associate Chief (MHC)
Joseph C. Guzzo, MD, Chief
Nelson P. Kopyt, DO, Associate Chief
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Department of Medicine (cont.)
Division of Neurology
Division of Physical Medicine & Rehabilitation
Division of Pulmonary
Division of Rheumatology

Alexander D. Rae-Grant, MD, Chief
Pradip K. Toshniwal, MD, Associate Chief (MHC)
Jane Dorval, MD, Chief
Jay H. Kaufman, MD, Chief
Brian Burlew, MD, Associate Chief (MHC)
Albert D. Abrams, MD, Chief
Ellen M. Field-Munves, MD, Associate Chief (MHC)

Department of Obstetrics and Gynecology
Stephen K. Klasko, MD, Chairperson
Ernest Y. Normington, MD, Vice Chairperson
Vincent Lucente, MD, Vice Chairperson
Stephen K. Klasko, MD, Residency Program Director
Craig J. Sobolewski, MD, Assistant Residency Program Director

(

Division of Obstetrics
Section of Maternal-Fetal Medicine
Section of Clinical Obstetrics
Division of Gynecology
Section of Synecologic Oncology
Section of Pelvic Reconstructive Surgery
Section of Reproductive
Endocrinology & Infertility
Division of Primary 08/SYN

James Balducci, MD, Chief
James Balducci, MD, Chief
Orion A. Rust, MD, Chief
Vincent R. Lucente, MD, Chief
Weldon E. Chafe, MD, Chief
Vincent R. Lucente, MD, Chief
Albert J. Peters, DO, Chief
Gregory J. Radio, MD, Chief

Department of Pathology
John J. Shane, MD, Chairperson
William B. Dupree, MD, Vice Chairperson

Division of Clinical & Anatomic
Division
Division
Division
Division

of
of
of
of

Dermatopathology
Forensic
Synecologic Pathology
Neurosciences

John J. Shane, MD, Chief (LVH)
Dion T. Manhoff, MD, Chief (MHC)
Howard B. Altman, MD, Chief
Isidore Mihalakis, MD, Chief
William B. Dupree, MD, Chief
(Vacant)

Department of Pediatrics
John D. VanBrakle, MD, Chairperson
Dennis W. Kean, MD, Vice Chairperson

(

Division
Division
Division
Division
Division
Division
Division
Division

of Allergy
of Behavioral Pediatrics
of Cardiology
of Development & Rehabilitation
of General Pediatrics
of Neonatology
of Neurology
of Pulmonary

(Vacant)
Sarah J. Fernsler, MD, Chief
Louis W. Hansrote, MD, Chief
Karen E. Senft, MD, Chief
Oscar A. Morffi, MD, Chief
Ian M. Gertner, MD, Chief
Martha A. Lusser, MD, Chief
Robert W. Miller, MD, Chief
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Department of Psychiatry
Michael W. Kaufmann, MD, Chairperson
Susan D. Wiley, MD, Vice Chairperson (LVH)
David L. Schwendeman, MD, Vice Chairperson (MHC)
Division of Adolescent Inpatient Psychiatry
Division of Adult Inpatient Psychiatry
Division of Consultation/Liaison Psychiatry
Division of Psychiatric Ambulatory Care
Division of Psychiatric Home Care

(

John F. Campion, MD, Chief
Clifford H. Schilke, MD, Co-Chief
Laurence P. Karper, MD, Co-Chief
Joseph L. Antonowicz, MD, Chief
Susan D. Wiley, MD, Chief (LVH)
Joel Lerman, MD, Chief (MHC)
Michael W. Kaufmann, MD, Chief

Department of Radiation Oncology
Victor R. Risch, MD, PhD, Chairperson
Charles F. Andrews, MD, Vice Chairperson

Department of Radiology/Diagnostic Medical Imaging
Robert Kricun, MD, Chairperson
Elliot I. Shoemaker, MD, Vice Chairperson (LVH)
Hal L. Folander, MD, Vice Chairperson (MHC)
John F. Cox, MD, Residency/Fellowship Program Director
Division of Diagnostic Radiology
Section of Chest
Section of Gastrointestinal
Section of Genitourinary
Section of Orthopedics
Section of Cardiovascular/Interventional
Section of Trauma/Emergency Medicine
Section of Pediatrics
Section of Neuroradiology
Section of Mammography
Division of Nuclear Medicine

Alan H. Wolson, MD, Chief
Alan H. Wolson, MD, Chief
Christopher L. Brown, MD, Chief
Christopher L. Brown, MD, Chief
John F. Cox, MD, Chief
James W. Jaffe, MD, Chief
Hal L. Folander, MD, Associate Chief (MHC)
James A. Newcomb, MD, Chief
Howard D. Rosenberg, MD, Co-Chief
Thomas R. Fitzsimmons, MD, Co-Chief
Elliot I. Shoemaker, MD, Chief
John G. Pearce, MD, Chief
Diane Garrigan, DO, Associate Chief (MHC)
Robert J. Rienzo, MD, Chief
Gregg D. Schubach, MD, Associate Chief (MHC)

Department of Surgery
Herbert C. Hoover, Jr., MD, Chairperson
Michael D. Pasquale, MD, Vice Chairperson for Clinical Affairs (LVH)
Gregory Brusko, DO, Vice Chairperson (MHC)
Mark C. Lester, MD, Vice Chairperson for Operations (Operating Room and OI)
Gary G. Nicholas, MD, Vice Chairperson of Educational Affairs
Walter :r. Okunski, MD, Senior Advisor to the Chair
Gary G. Nicholas, MD, General Surgery Residency Program Director/Education Director
Robert D. Riether, MD, Colon/Rectal Residency Program Director
Walter J. Okunski, MD, Plastic Surgery Residency Program Director

(
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Medical Staff Department Chairpersons and Chiefs of Divisions and Sections - 1999/2000
Department of Surgery (cont.)

(

Michael D. Pasquale, MD, Surgical Critical Care Residency Program Director
Scott W. Beman, MD, Chief Surgical Resident
Michael T. Kennedy, MD, Chief Surgical Resident
Rovinder S. Sandhu, MD, Chief Surgical Resident
Division of Cardio-thoracic Surgery
Division of Colon/Rectal Surgery
Division of General Surgery

Section of Pediatric Surgery
Section of Transplantation Surgery
Division of Hand SUrgery
Division of Neurological Surgery
Section of Neuro Trauma
Division of Ophthalmology

Division of Oral/Maxillofacial Surgery

(

Division of Orthopedic Surgery

Section of Foot and Ankle Surgery
Section of Ortho Trauma
Division of Otolaryngology
Division of Plastic/Reconstructive Surgery

Division of Trauma-Surgical Critical Care
Section of Burn
Section of Pediatric Trauma
Section of Trauma Research
Division of Urology
Division of Vascular Surgery

Michael C. Sinclair, MD, Acting Chief
John J. Stasik, MD, Chief
Lester Rosen, MD, Associate Chief
Gerald P. Sherwin, MD, Chief
Douglas R. Trostle, MD, Associate Chief (LVH)
Gregory Brusko, DO, Associate Chief (MHC)
Chris CN. Chang, MD, Chief
Craig R. Reckard, MD, Chief
Michael A. Chernofsky, MD, Chief
Mark C. Lester, MD, Chief
Robert P. Marcincin, MD, Associate Chief (MHC)
(Vacant)
Glen L. Oliver, MD, Chief
Alan B. Leahey, MD, Associate Chief (LVH)
Steven J. Kanoff, MD, Associate Chief (MHC)
Mark H. Grim, DMD, Chief
Jonathan A. Tenzer, DMD, Associate Chief (MHC)
Peter A. Keblish, Jr., MD, Chief
George A. Arangio, MD, Associate Chief (LVH)
Ranjan Sachdev, MD, Associate Chief (MHC)
Chief (Vacant)
David P. Steed, DPM, Associate Chief
Patrick B. Respet, MD, Chief
John D. Harwick, MD, Chief
John S. Papola, MD, Associate Chief
Walter J. Okunski, MD, Chief
Geoffrey G. Hallock, MD, Associate Chief (LVH)
Manny Iyer, MD, Associate Chief (MHC)
Michael D. Pasquale, MD, Chief
Mark D. Cipolle, MD, PhD, Associate Chief
Kevin J. Farrell, MD, Chief
Walter J. Okunski, MD, Associate Chief
James G. Cushman, MD, Chief
Mark D. Cipolle, MD, PhD, Chief
Edward M. Mullin, Jr., MD, Chief
Richard M. Lieberman, MD, Associate Chief
Gary G. Nicholas, MD, Chief
James G. Goodreau, MD, Associate Chief (LVH)
Marc A. Granson, MD, Associate Chief (MHC)

(
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Medical Directors of Patient Care Units,
Laboratories and Programs
1999-2000

(

(Approved by LVH Board of Trustees - 6/2/99
and MHC Board of Trustees - 6/8/99)

Medical Critical Care Director - Richard H. Snyder, MD
Surgical Critical Care Director - Michael D. Pasquale, MD

Cedar Crest & I-78
Acute Care Unit
Burn Unit
Dialysis
Invasive Cardiology
Medical Intensive Care Unit
Open Heart Unit
Operating Room
Progressive Coronary Care Unit
Post Anesthesia Care Unit
Special Care Unit
Surgical Intensive Care Unit
Transitional Open Heart Unit
Transitional Trauma Unit
Trauma/Neuro Intensive Care Unit
4A

4B

4C
5B

5C
6B

6C
7A
7B

- Bryan W. Kluck, [)0
- Walter J. Okunski, MD/Kevin J. Farrell, MD
-James E. Kintzel, MD
- D. Lynn Morris, MD
-JayS. Cowen, MD
-Stephen C. Matchett, MD {Associate Medical Director)
- Theodore G. Phillips, MD
-Mark C. Lester, MD/Thomas M. McLoughlin, Jr., MD
-Bryan W. Kluck, [)0
-Karen A. Bretz, MD
- Stephen C. Matchett, MD
-Mark D. Cipolle, MD, PhD
(
- Theodore G. Phillips, MD
-Kevin E. Glancy, MD
-Michael D. Pasquale, MD/Mark C. Lester, MD
-Bruce A. Feldman, [)0/J. Harry Pickle IV, MD
- L. Kyle Walker, MD
- Gary G. Nicholas, MD
-Gerald P. Sherwin, MD/Brian P. Murphy, MD
-Peter A. Keblish, Jr., MD
-Stephen R. Shore, MD/Mark C. Lester, MD
-Gregory R. Harper, MD, Ph[)/[)avid M. Caccese, MD
- Drew S. Harrison, MD
- Yehia Y. Mishriki, MD

(
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17th & Chew

(
Ambulatory Surgery Unit
Labor & Delivery Room
Mother/Baby
Neonatal Intensive Care Unit
Pediatric Ambulatory Surgery Unit
High Risk Perinatal Unit
Perinatal Center
Post Anesthesia Care Unit
LVTSU (Hospital-based Skilled Nursing Facility)

4S
Adolescent Psychiatry
Adult Psychiatry:

- 6N
- 6S
Behavioral Health Emergency Services

- J. John Collins, MD/Walter J. Okunski, MD
- Orion A. Rust, MD
- Orion A. Rust, MD/Ian M. Gertner, MD
- Ian M. Gertner, MD
-John D; Harwick, MD
- James Balducci, MD
- Robert 0. Atlas, MD
- Karen A. Bretz, MD/J. John Collins, MD
- David P. Carney, MD
-Steven A. Scott, MD (Associate Medical Director)

- Vincent R. Lucente, MD
-John F. Campion, MD
- Clifford H. Schilke, MD
-Laurence P. Karper, MD
-Laurence P. Karper, MD

Muhlenberg Hospital Center

(

3S/4S
Operating Room/ Ambulatory Surgical Unit
Post Anesthesia Care Unit
Psychiatry
Respiratory
Short Procedure Unit

-Jonathan H. Munves, MD
- Gregory Brusko, DO
- Domenico Falcone, MD
- David L. Schwendeman, MD
-Douglas F. Turtzo, MD
- Anthony D. Dippolito, MD

Off-Site Programs
Adolescent Partial Hospitalization Program
Adult Partial Hospitalization Program
Guidance Program
Transitional Living Center

(

-James G. Showalter, MD
- Ralph A. Primelo, MD
-Susan D. Wiley, MD
- Susan D. Wiley, MD

Medical Directors of Patient Care Units, l.aboratories and Programs- 1999/2000
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LABORATORY AND OTHER SERVICE MEDICAL DIRECTORS

(

John & DorDthy Morgan CtUICer Center

Director
Associate Director, Research
Associate Director, Education
Associate Director, Cancer Control
Director, Breast Health Services
Associate Director, Breast Health Services
Director, Breast Imaging

- Gregory R. Harper, MD, PhD
-Herbert C. Hoover, Jr., MD
-Victor R. Risch, MD, PhD
- Mark J. Young, MD
-Gregory R. Harper, MD, PhD
-John G. Pearce, MD
- John G. Pearce, MD

HospitDI Ltzb/Service Directors

Cardiac Catheterization Lab (Invasive Cardiology)
Center for Women's Medicine Perinatal Testing
Endocrine Testing Station
GI Labs
Helwig Diabetes Center
MedEvac/Emergency Med Institute
Metabolic Bone Program
NeuroDiagnostic Lab
Pediatric Ambulatory Care
Pre-Admission Testing
Pulmonary Lab
Respiratory Care
Sleep Disorders Lab
Vascular Lab

- D. Lynn Morris, MD
- Vincent R. Lucente, MD
- Dean F. Dimick, MD
-Carl F. D'Angelo, MD
-Robert D. Riether, MD (Associate Medical Director)
- Larry N. Merkle, MD
-John F. McCarthy, DO
- Donald E. Barilla, MD
- Alexander D. Rae-Grant, MD
(
- Kimberly C. Brown, MD
- Karen A. Bretz, MD
-John P. Galgon, MD
-Jonathan Hertz, MD
- John P. Galgon, MD
- William Gee, MD
-Gary G. Nicholas, MD (Assoc. Medical Director- LVH)
-James D. Balshi, MD (Assoc. Medical Director- MHC)

Het1/th Network LtzbortZtories

Anatomic Pathology
Clinical Lab
Cytopathology Lab
Dermatopathology
Transfusion Medicine & HLA Lab

- John J. Shane, MD
-David Beckwith, PhD (Director)
-William B. Dupree, MD
-Howard B. Altman, MD
- Bola B. Carver, MD
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GUIDELINES FOR CONSULTATIONS

(

Physicians are professionals, and as professionals, expect and deserve a certain amount of
respect from their physician colleagues. We have had some discussions about the process
of requesting and performing consultations at this hospital, and how this process might be
improved.
The following suggestions are offered as "guidelines" both for physicians requesting
consultations, and for physicians performing consultations. Much of what follows has been
previously suggested by Dr. John Van.Brakle and is not original with me. Also, much of
what follows is simply a reflection of the type of professional behavior which I believe all
of us learned at one time, but are now often too busy to follow. In addition, I believe that if
the "guidelines" were followed we would significantly improve professional and patient
communication, improve the quality of patient care, and reduce the cost of the care which
we deliver to our patients.
Remember, the request for a consultation from the attending physician to another physician
or health care professional is a request for an opinion regarding a specific issue related to the
patient's diagnosis or care.

(

•

The consultation request should address a specific question or a specific need. e.g .
"Please help diagnose my patient's problem", "Please recommend the best treatment
for my patient's condition", "Please evaluate my patient medically before a planned
operation", or "Please see my patient for possible abdominal aortic aneurysm repair",
etc.

•

A personal call to the consultant from the attending physician stating the reason for
the consultation request, what is expected from the consultant, and whether orders
should be written by the consultant is appropriate, encouraged, and a simple
professional courtesy. The attending/referring physician may lmow or have
information about the patient which is not available in the medical record which
would be helpful for the consultant to lmow.

•

It should be clear in the consultation request whether the attending physician is
requesting the consultant's advice, opinion, or direct involvement in the patient's care.

•

"Courtesy Consultations" are appropriate and should be placed to physicians who
have been closely involved with the patient's care, but whose opinion is not
necessarily needed or required by the attending physician. An example would be a
"courtesy consultation" to the patient's family physician by the attending surgeon
who is preparing the patient for an uncomplicated mastectomy. A patient charge
should not be generated for a "courtesy consultation".
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•

"Teaching Consultations" are also appropriate for the benefit of residents in training
and medical students when an interesting or unusual patient problem becomes
apparent to the attending physician, but the services of another physician are not
necessarily required. Patients should be informed that their problem is unusual or
interesting and asked if it would be acceptable to have another physician and some
resident physicians stop by to review the patient's record and briefly interview and
examine the patient. A patient charge should not be generated for a "teaching
consultation". This type of consultation is in the best interest of the goals of a
teaching institution, its medical staff, resident physicians, and students.

•

It should be made clear at the time of the request for the consultation whether the

(

attending physician wants the consultant to discuss his/her findings and
recommendations with the patient and the patient's family or whether the
recommendations should be discussed with the attending physician either solely or
primarily.
•

•

The consultant should always introduce him/herself to the patient and his family if
they are present. He/she should inform the patient and family that he has come to see
the patient at the request of the attending physician and should mention the referring
physician by name. He/she should specify why he was asked to see the patient by the
referring physician. It is also helpful to ask the name of the patient's primary care
physician. After the evaluation the consultant should tell the patient that he will
discuss his findings and recommendations with the patient's attending physician and
that together they will develop a plan for the patient's future care.

(

It is useful for the consultant to provide his professional card or to provide his name

in writing to the patient and his/her family.
•

After the consultation is performed, a personal call from the consultant to the
attending physician detailing the findings, recommendations, and suggestions
regarding the further involvement of the consultant in the patient's care is appropriate
as a professional courtesy and in the interests of the highest quality patient care. The
initial question asked by the attending physician should be answered by the consultant
at this time.

•

At this point, it should be clarified as to whether the attending physician wants to
write all of the orders in the patient's chart or whether the consultant has the authority
to write orders for diagnostic tests and treatments.

•

The consultant should not write an order for another consultant to see the patient
without discussing this with the attending physician. The consultant should not order
an invasive diagnostic or therapeutic procedure for a patient without first discussing
this with the attending physician. Do not write an order unless specifically cleared

(
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by the attending physician. You are offering an opinion which the attending
physician may or may not choose to follow.

(

(

•

As a consultant, discuss the need for post discharge follow up of the patient with the
attending physician.

•

If the consultation request is for "patient management" and the consultant feels that
the extent of his/her involvement would be best served by a transfer from the referring
physician to the consultant's service, this should be discussed with the attending
physician after the patient is seen and evaluated.

•

The consultation report should be completed before the consultant leaves the patient
care unit. This note should answer the question which was originally addressed in the
consultation. The note may be brief, but should be followed by a longer more
detailed note, preferably one which is dictated and transcribed so that it will become
a legible part of the patient's permanent medical record. References can be provided
if useful, but not simply to "show off'.

•

It is useful to have a copy of the detailed consultation report mailed to the attending
physician as well as to the patient's primary care physician.

•

As a consultant, never criticize the previous or present treatment to the patient or
his/her family.

•

As a consultant, if you have strong objections to the patient's present diagnosis or
treatment, do not start an argument in the medical record. Discuss you opinions with
the referring physician directly.

•

As an immediate response it is acceptable to say "I don't know, but I will find out"
or "I need a little time to think and/or talk this over with someone else". This is
preferable to guessing. If you really don't know -look it up!

Hopefully by following the above simple guidelines we will improve communication
between physicians and between physicians and patients. This improvement in
communication will lead to better professional relationships between physicians and health
care providers and may significantly reduce the risk of medical malpractice. I believe that
if these guidelines are followed we also may see a significant reduction in the duplication of
studies and in the cost of care which we deliver to our patients.

David M. Caccese, M.D.
July 1, 1997
consult. wpd
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John E. Stahler, M.D. and James C. Rex,
M.D. Surgery Research Award-Michael
Morrissey, MD.

Announcements:
The following awards were presented at the
1999 Resident Graduation Ceremony held on
June 11, 1999.

Paul R. Bosanac, M.D. Research AwardMichael Kennedy, MD.

Clinical Teacher of the Year in DentistryGregory Dimmich, DMD

Society of Teachers ofFamily Medicine
Resident Teacher Award-Andrew McLaren,
M.D.

Clinical Teacher of the Year in Obstetrics
and Gynecology-Michael Sheinberg, MD.

Hahnemann University School ofMedicine
Dean's Special Award for Excellence in
Clinical Teaching-Brian Stello, MD.

Clinical Teacher ofthe Year in Colon and
Rectal Surgery-Robert D. Riether, MD.

(

Penn State College ofMedicine Award for
Excellence in Clinical Teaching for the
Department of Obstetrics and GynecologyJames Balducci, M.D.

Clinical Teacher of the Year in General
Surgery-Gerald Sherwin, MD.
Clinical Teacher of the Year in Internal
Medicine-Yehia Mishriki, MD.

Fred D. Fister, M.D. Family Physician
Award-Susan Snyder Mathieu, MD.

Headley White Award for Outstanding
Teacher in Family Practice-Joanne CohenKatz, Ph.D.

News from the Library

Diagnostic Radiology Case of the Week
Award-Randolph Wojcik, MD.

OVID/PubMed TRAINING.

To schedule one-on-one OVID (MEDLINE)
training session, call Barbara Iobst in the
Health Sciences Library at 402-8408.
Barbara can also instruct you in the use of
PubMed, a free, Web-based MEDLINE
service offered by the National Library of
Medicine (NLM). MEDLINE can be
searched directly using PubMed.

Obstetrics and Gynecology National Faculty
Award for Excellence in Resident Education
(CREOG) Award-Craig Sobolewski, MD.
Stephen Renner, D.O. Excellence in
Cardiology Award-Nainesh Patel, MD. and
Paresh Shah, MD.

1
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New Publications- Cedar Crest & 1-78

News from the Office of
Educational Technology

"Hematology/Oncology Clinics ofNorth
America" Subject: "Advances in Breast
Cancer Therapy" Guest Editor: G. Sledge,
Jr. Volume 13, No. 2, 1999

(

Computer-Basecl Training (CBD:
. CBT has replaced instructor-led classes
previously held at LVH. A proctor will be in
the room with the learner while s/he takes
the CBT, but the learner will control the
pace and objectives of the learning.
Topics covered by CBT include:
Access 2.0 & 97, Windows NT 4, Word 97,
Excel 97, PowerPoint 97, PHAMIS
Lastword Inquiry only, & E-mail GUI

"Endovascular Skills: Guidewires, Catheters,
Arteriography, Balloon Angioplasty, Stents''
Author: P. Schneider - Call No. WG 170
S359e 1998
"Bates' Guide to Physical Examinationa and
History Taking," 7th edition Editor: L.
Bickley, et al. - Call No. WB 205 B583b
1999 (Reference Book).

CBT takes place. in JDMCC, Suite 401.
From April through December 1999, there
will be two CBT sessions every Tuesday.
The morning session is 8:00 am to noon.
The afternoon session is 12:30 to 4:30 pm.
Twelve slots are available for each session.

New Publications - 17th And Chew
"Principles Of Manual Medicine," 2nd
edition Author: P. Greenman- Call No.
WB460G814p

To register, please contact Bonnie
Schoenebergervia email or at 402-1210.
If you have questions regarding CBT,contact
Craig Koller via email or at 402-1427.

"Maternal-Fetal Medicine," 4th edition
Author: R Creasy, et al.- Call No. WQ 211
M425 1999.

(

PC BasicL Windows NT[2S & Email:
The following classes will be held at MHC in
the liS Training Room off the lobby of the
main building. Please call317-4771 to
register. Registration is required.

New Publications - Muhlenberg
Hospital Center
"Emergency Medicine: Concepts and Clinical
Practice," 4th edition. Editor: P. Rosen, et
al. - Call No. WB 105 ESSS 1998.

MICBOMEDEX.

PC Basics
July 9 - 9-llam.
July 23 - 9-11am.

MICROMEDEX, a drug-information
database, will be provided through the
Hospital's Intranet in a slightly different
format in the near future. Details will follow.

Windows NT/95
July 9 - 1-3pm
July 23 - 1-3pm
Emaillntro.
July 2 - 9-llam.
July 16- 9-llam
July 30- 9-llam.
2
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Grand Round and
Tumor Board Schedule

1999

Jul

SUNDAY

MONDAY

THURSDAY

WEDNESDAY

TUESDAY

12 Noon Combined
Tumor Board - JDMCC CR1NB

FRIDAY
I 7am OBGYN Grand
Rounds -17 Aud

SATURDAY
1

3

9

10

16

17

D

14

30

ll

12 Noon Breast Tumor
Board • JDMCC. CR1 NB

4 He!Way

5

7 am Surgical Grand
Rouncla- CC-Aud

8

7am OBGYN Grand
Rounds -17 Aud

8am Pedlalric Grand
Rouncla- 17-Aud

12 Noon Pediatric Noon
Conf·17Aud

12 Noon Medical Grand
Rouncla CC-Aud

12 Noon Breast Tumor
Board • JDMCc- CR1 NB

11 7am Ambulatory Clln

II

7 12 Noon Combined
Tumor Board • JDMCC •
CR1NB

6

Guideline Ow· SON

IJ 12 Noon Pulmonary Tumor
Board· JDMCC • CR1 NB

M 12 Noon Combined

Tumor Board • JDMCC •
CR1NB

IS 7am OBGYN Grand
Rounds -17 Aud

12 Noon Breast Tumor
Board • JDMCC- CR1 AlB

7 am Surgical Grand
Rouncla-CC-Aud·
Bam Pediatric Grand
Rouncla -17-Aud
12 Noon Medical Grand
Rounds cc-Aud

II 12 CIR Tumor Board •
JDMCC • CR1 NB

15

19 7 am Surgical Grand
Rounds· CC-Aud

16

10

11 12 Noon Combined

Tumor Board - JDMCC •
CR1NB

ll 7am OBGYN Grand
Rounda-17 Aud

Bam Pedlltric Grand
Rouncla -17-Aud

12 Noon Pediatric Noon
Conf-17Aud

12 Noon Medical Grand
Rounds cc-Aud

12 Noon Breast Tumor
Board • JDMCc- CR1 AlB

7 am Suflllcal Grand
Rounda·CC-Aud·
Bam Pediatric Grand
Rounds- 17-Aud
12 Noon Medical Grand
Rounds CC-Aud
12 Noon UrolOgy Tumor
Board • JDMCC • CR1
AlB

17

18

12 Noon Combined
Tumor Board - JDMCC •
CR1NB

19

7am OBGYN Grand
RoundiiiTumor Board -17

Aud
12 Noon Breast Tumor
Board • JDMCC- CR1 AlB
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Medical Staff Progress Notes
is published monthly to
inform the Medical staff of
Lehigh Valley Hospital and
employees of important
issues concerning the
Medical staffs.
Articles should be submitted
to Janet M. Seifert, Physician
Relations, Lehigh Valley
Hospital, C8dar Crest & 1·78,
P.O. Box 689, Allentown, PA
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questions about the
newsletter, please call Mrs.
Seifert at (610) 402·8590.
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